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A tube latex agglutination test (LAT) for diagnosis of Mycoplasma 
hyopneumoniae swine pneumonia was developed. In M. hyopneumoniae inocu­
lated pigs, LAT antibodies were generally detected 2 to 3 weeks post-
inoculation, which was 1 week or more before complement-fixation anti­
bodies were first detected in the corresponding pigs. Correlation of LAT 
results and gross and microscopic lung lesions of corresponding pigs re­
vealed that LAT titers persisted after the pneumonic lesions had resolved. 
Latex agglutination titers in contact exposed pigs were demonstrated 
4 to 12 weeks post-contact with M. hyopneumoniae inoculated pigs. 
Latex agglutination antibodies were detected up to 48 weeks post-
inoculation in M. hyopneumoniae inoculated pigs which was similar to the 
duration of indirect hemagglutination titers. Complement-fixation titers, 
however, were demonstrated no longer than 28 weeks post-inoculation in 
corresponding pigs. 
Diethyl aminoethyl (DEAE) cellulose and 2-mercaptoethanol treatments 
of sera from H. hyopneumoniae inoculated pigs indicated latex agglutina­
tion antibodies probably were 19S immunoglobulins. 
Evaluation of repeatability of LAT results revealed some variation 
of LAT titers of sera titered at four different times. 
Sera from pigs inoculated with other swine mycoplasmas, including M. 
hyosynoviae and ^ hyorhinis, did not react in the ^ hyopneumoniae LAT. 
In addition, no detectable titers were demonstrated in the M. hyopneu­
moniae LAT using sera from pigs infected with Metastronqylus spp.. Ascaris 
iv 
suum, or in sera from pigs vaccinated with any of four commonly used swine 
vaccines. 
Attempts to remove nonspecific agglutinins from swine test sera using 
swine or sheep RBC absorption were partially successful. 
Chemical and physical treatments of M. hyopneumoniae resulted in 
fractions that possessed LAT antigen activity in varying degrees. 
Field evaluation of the LAT demonstrated a degree of correlation of 
LAT results with complement fixation test results, and with gross and 
microscopic lung lesions. 
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INTRODUCTION 
Mycoplasmal pneumonia of swine (MPS) is a chronic, worldwide pneumo­
nia characterized by a dry, nonproductive cough, loss of vigor, reduced 
feed efficiency and growth rate, high morbidity and low mortality. For­
merly known as virus pneumonia of pigs (VPP), and later as enzootic pneu­
monia of pigs (EPP), mycoplasmal pneumonia of swine is caused by Myco­
plasma hyopneumoniae (Mare and Switzer, 1965). In naturally occurring 
infections, M. hyopneumoniae is transmitted by aerosal or pig-to-pig con­
tact. Other than the pig, M. hyopneumoniae has no other known reservoirs 
or vectors. Lungs from pigs affected with MPS have well-defined areas of 
plum colored lesions, usually located in the cardiac and apical lobes. 
Microscopic lung changes include peribronchiolar and perivascular lymphoid 
hyperplasia, septal cell proliferation, and thickening of alveolar walls. 
Because of the chronic nature of the disease and the increased sus­
ceptibility of pigs with MPS to other pneumonia producing agents, myco­
plasmal pneumonia of swine is of great economic effect. To minimize the 
economic effect of MPS, it is important that herds free from MPS be 
established. Drug and antibiotic therapy has failed to achieve this goal. 
At best, certain drugs and antibiotics can prevent pneumonic lesion for­
mation in pigs if administered prior to M. hyopneumoniae infection. Pigs 
treated with these antibiotics and drugs, however, can still transmit M. 
hyopneumoniae and, upon removal of the drug or antibiotic, can develop 
pneumonic lesions. 
Another way to free swine herds from MPS would be to utilize sero­
logical tests for the diagnosis of the disease. In this way, pigs 
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positive for MPS in a serological test could be removed. By periodic 
testing of the herd and removal of any positive pig, MPS-free herds might 
be started and maintained. Original work with a microti ter complement 
fixation (CF) test met with some success in accomplishing this goal. 
Lack of adequate sensitivity of the CF test, however, apparently allowed 
a few M. hyopneumoniae positive pigs to remain undetected by the CF test. 
Gradually, the incidence of MPS could increase from these few M. hyopneu­
moniae infected CF negative pigs. 
Due to the partial success of the CF test in starting and maintaining 
herds free of MPS, attention was directed to other serological tests. The 
latex agglutination test (LAT) was chosen for several reasons: 1) previ­
ous work indicated other mycoplasmal infections in swine could be detected 
with the LAT; 2) the LAT was regarded as more sensitive than the CF test; 
and 3) the LAT was conducive to testing a reasonable number of serum 
samples at a economy of time, space, equipment, and cost. 
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LITERATURE REVIEW 
A review of the literature concerning: 1) the latex agglutination 
test as a serological test for diagnosis of animal and plant diseases; and 
2) serological tests for diagnosis of Mycoplasma h.yopneumoniae swine 
pneumonia is presented. 
Latex Agglutination Test 
The latex agglutination test (LAT) as a serological technique was 
first described by Singer and Plotz (1956). By interacting a gamma 
globulin-latex complex with serum from patients with rheumatoid arthritis, 
the authors observed visible agglutination. Evaluation of these latex 
agglutination test results indicated that the test compared favorably with 
the commonly used Rose-Ragan sheep method for the diagnosis of human 
rheumatoid arthritis (Rose et al., 1948). 
A more detailed description of the ability of the LAT to detect the 
rheumatoid factor was presented by Singer (1961). He reported that a 
standardized latex particle suspension which had a total surface area of 
9.2 cm2 could absorb 1.46 yg of human gamma globulin nitrogen per ml. 
Thus, it was possible for one 0.81 y latex particle to absorb a maximum 
of 75,000 molecules of gamma globulin. Because unabsorbed gamma globulin 
did not inhibit latex agglutination. Singer postulated that the gamma 
globulin that was complexed with the latex particles either aggregated or 
changed in configuration upon adsorption to latex in order for it to react 
with the rheumatoid factor. 
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Since the basic work by Singer, many workers including MacSween 
et al. (1972), Muic et al. (1972), West et al. (1974), and Bayless et al. 
(1971) have evaluated the LAT as a diagnostic test for detection of the 
rheumatoid factor in serum. The general conclusion was that when time, 
cost, and accuracy were all considered, the LAT was the test of choice for 
diagnosing rheumatoid arthritis. 
Carlisle and Saslaw (1958) were the first to use polystyrene latex 
particles as carriers for histoplasmin. Their results demonstrated that 
a tube LAT was as accurate in diagnosing histoplasmosis as was the 
collodion agglutination test developed by Saslaw and Campbell (1950). 
More extensive work involving the LAT in the diagnosis of histoplasmosis 
was done by Gerber et al. (1972). They found the microti ter latex agglu­
tination test was not only as sensitive as the complement fixation (CF) 
test for diagnosis of histoplasmosis, but also had several distinct ad­
vantages. Because the LAT titers fell more rapidly than did the CF titers 
after acute histoplasmosis, the LAT titers were more indicative of an 
active infection. Also, sera that were anti-complementary in the CF test 
gave suitable LAT titers. 
Muraschi (1958) successfully used the LAT for serodiagnosis of 
leptospirosis. He found the LAT was comparable in sensitivity and speci­
ficity with the standard agglutination-lysis and microscopic-agglutination 
tests. Similar results were reported by Kelen and Labzoffsky (1960). 
In an initial study of the latex agglutination test for the diagnosis 
of disseminated lupus erythematosus (OLE), Singer and Plotz (1956) found 
latex particles coated with calf thymus nucleoprotein were agglutinated by 
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many OLE sera. Later work by Christian et al. (1958) demonstrated that 
deoxyribonucleic acid in small amounts inhibited the nucleoprotein latex 
agglutination test. More recently, work by Cracchiolo and Barnett (1972) 
indicated the LAT could detect antinuclear antibodies in both synovial 
fluid and serum of patients with systemic lupus erythematosus. 
Singer et al. (1957) compared the ability of the capillary precipitin 
test and the LAT in detecting the C-reactive protein, a protein present in 
the sera of people with a variety of diseases. Their results indicated 
similar sensitivity and specificity of the two tests in determining C-
reactive protein in serum. More recently, Alvarez-Lopez (1972) reported 
the latex agglutination test could be used in the diagnosis of many in­
flammatory diseases caused by infectious organisms including various 
Brucella and Salmonella species and Streptococcus pyogenes. 
Keele and Webster (1961) found a latex-gamma globulin complex spe­
cific for human growth hormone was agglutinated in the presence of human 
growth hormone. Robbins et al. (1962) reported that latex particles 
coated with human gonadotropin agglutinated in the presence of immune 
rabbit serum. Later work by Bermes and Isaacs (1969) showed a direct 
agglutination latex particle slide test could detect human chorionic 
gonadotropin (HCG). By using latex particles coated with anti-HCG, the 
test had an accuracy rate of 98%. The test could be used on serum or 
urine with no interference from protein in the urine. A semi-quantita­
tive latex agglutination test for HCG devised by Hechtermans and Baleriaux 
(1972) and a latex tube agglutination-inhibition test for HCG developed by 
Horwitz (1973) also gave approximately 98% accuracy as pregnancy tests. 
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To detect the presence of fibrin degradation products (FDP), products 
appearing in the blood of patients with toxemia, placental insufficiency, 
and other pregnancy problems, Svanberg et al. (1974) developed a latex 
agglutination-inhibition test. They found that at concentrations of FDP 
above 15 pg/ml, the latex agglutination-inhibition test results were in 
complete agreement with immunochemical determinations of FDP. 
Ross et al. (1975) used a latex agglutination-inhibition tube test 
to detect the presence or absence of morphine in sera and urine of human 
morphine addicts and nonaddicts. Of 506 radioimmunoassay morphine nega­
tive urine samples, 99.6% were latex agglutination-inhibition negative. 
Latex agglutination-inhibition testing of radioimmunoassay morphone posi­
tive sera resulted in 94.3% of the sera being test positive. Sensitivity 
studies revealed that the latex agglutination-inhibition test could detect 
as little as 40 ng per milliter of morphine in sera or urine samples. 
The appearance of alpha fetoprotein (AFP) in human sera has been 
associated with a variety of disease conditions including liver carci­
nomas (Alpert et al., 1971), gonadal terablastoma (Abelev et al., 1967), 
and fetal distress (Seppala and Ruoslahti, 1973). As a rapid method to 
detect AFP, Alpert and Coston (1973) evaluated the LAT. By using rabbit 
anti-AFP attached to latex, they found 86% of the sera positive in counter 
immunoelectrophoresis were positive in the LAT. A major disadvantage of 
the LAT was the occurrence of nonspecific agglutination. Sera from 8% of 
people with hepatomas and 10% of people with other liver diseases agglu­
tinated normal rabbit gamma globulin coated latex. 
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An evaluation of the LAT for detection of hepatitis associated 
antigen (HAA) by Cleator et al. (1973) revealed approximately 5% false 
negatives and 4% false positives. Other workers, including Banatvala 
et al. (1971) and Lehmann and Gust (1973), reported similar problems 
with false positives and negatives. 
Kirsner et al. (1973) used LAT to study patients with idiopathic 
cardiomyopathy. They found 19% of the patients had a positive thyroid 
antibody latex test and 28% had positive latex agglutination test results 
for heart reactive factors. No correlation was found between the positive 
latex tests and the clinical course or severity of the disease. 
During the serological study of proven cases of sporotrichosis 
representing cutaneous, subcutaneous, and extracutaneous forms of the 
disease, Blumer et al. (1973) developed a slide latex agglutination (SLA) 
test and compared it with tube agglutination (TA), CF, immunodiffusion 
(ID), and indirect fluorescent antibody (IFA) tests. With filtrate anti­
gens from yeast forms of Sporothrix schenckii sensitized latex particles, 
the SLA test detected antibodies in sera of 94% of 80 patients with 
sporotrichosis, while the TA detected 96%, the IFA 90%, the CF test 68%, 
and the ID 56%. Sera from 86 apparently healthy individuals were tested 
for sporotrichosis. Only the SLA and ID tests showed no reaction. 
In checking antibody responses in patients with farmer's lung disease 
due to Thermoactinomyces vulgaris, Hollingdale (1975) compared the LAT to 
several other serological tests. His results indicated a combination of 
latex agglutination and counter immunoelectrophoresis gave the highest 
accuracy rate in diagnosing the disease. 
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Varela-Diaz et al. (1975) evaluated the indirect hemagglutination 
(IHA), latex agglutination, and immunoelectrophoresis (lEP) tests as 
diagnostic tests for human hyatid diseases. In general, results indicated 
that the IHA test was more sensitive but less specific than the LAT. 
These results were in agreement with Williams and Prezioso (1970). 
Morris et al. (1970) developed a slide latex agglutination test 
for invasive amoebiasis. They found that over 95% of the sera from 
patients with either amoebic liver abscesses or amoebic dysentery were 
positive in the slide LAT. A relative high frequency of positive results 
in the LAT occurred with sera from people with no overt clinical signs. 
Additional studies on amoebiasis by Monroe et al. (1972) demonstrated that 
the LAT was more sensitive than the gel diffusion precipitin test for 
invasive amoebiasis diagnosis. Again, a major drawback of the LAT was the 
high numbers of LAT titers found in sera from asymptomatic patients. 
Further work by Sodeman and Dowda (1973) indicated the IHA test was a 
more sensitive indicator of anti-Entamoeba histolytica serum antibody than 
were cellulose acetate diffusion, agar gel diffusion, or latex agglutina­
tion tests. Stamm et al. (1973), however, found the latex agglutination 
test and the IHA test to be similar in their ability to detect E. 
histolytica antibodies. 
Molina and Saletti (1961) first used the LAT for detection of anti­
body to the M protein antigen of Streptococcus pyogenes. Later work by 
Koehler and Kuehnemund (1973) compared antibody response in rabbits to 
Strep, pyogenes using LAT, Ouchterlony test, long-chain reaction test, and 
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indirect bactericidal test. The LAT and Ouchterlony tests detected the 
earliest positive antibody titers after the immunization of rabbits. 
Johnson (1970) compared antigenic properties of two proteins of 
Ascaris suum using the latex agglutination test with sera from pigs in­
fected with Ascaris suum. Later work by Poletaeva and Fedorova (1972) 
showed that the LAT and hemagglutination test detected antibodies of both 
IgG and IgM class in sera from rabbits experimentally infected with 
Ascaris suum . 
An evaluation of the lactic dehydrogenase isoenzyme test and coc-
cicioidin latex agglutination test for diagnosis of induced Coccidioides 
immitis meningitis in rabbits by Sorensen (1973) revealed both tests were 
more specific than previously used testi, and detected the meningitis in 
an early stage. 
Cole et al. (1972) evaluated a simple latex agglutination test (SLAT) 
for diagnosis of tuberculosis. He found that from bacteriologically con­
firmed TB cases, over 80% of the people showed SLAT titers, while in 
arrested cases 91% of the patients showed SLAT titers. Cole's work sug­
gested that the SLAT test might be a suitable replacement for the skin 
test as a screening test for tuberculosis. 
Reports by Todorovic (1971) indicated that the LAT might have appli­
cation in diagnosis of Babesia infection of cattle. 
Rombert and Vieira (1971) used a latex test to detect antibodies in 
serum from dogs infected with Ancyclostoma caninum. They found the latex 
test detected antibodies as soon as 10 days post-infection with a peak at 
3 months. 
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Bennett and Bailey (1971) extended the work of Bloomfield et al. 
(1963) concerning detection of Cryptococcus neoformans antigens in body 
fluid by the LAT. Bennett and Bailey found that the 10% false positives 
were largely due to the rheumatoid factor present in the sera. With the 
added control of latex coated with normal rabbit globulin to detect false 
positive serum samples, the LAT results were found to compare favorably 
with the CF test in detecting Cryptococcus neoformans antibodies. 
The feasibility of the latex test for serologically detecting plant 
viruses was reported by Bercks (1967). By using latex coated with anti­
body, Bercks was able to detect much lower virus concentrations than with 
the slide precipitin or agar double-diffusion tests. In a more recent 
study, Bercks and Querfurth (1971) found that serological relationships 
among plant viruses could be detected by adsorbing viruses indirectly to 
latex particles coated with antibodies. 
In a comparison of indirect hemagglutination and latex agglutination 
tests for detection of plant viruses, Salih et al. (1968) noted that al­
though the LAT was eight to 40 times less sensitive than IHA, less anti­
body was needed to sensitize the latex particles than was required to 
sensitize RBC. Thus, antisera with titers too low to use in the IHA test 
could be used in the LAT. 
Carter (1973) and Bercks and Querfurth (1969) found their latex 
agglutination tests were more sensitive than Salih's and suggested that 
the LAT was equally as sensitive as the IHA test. In the same paper. 
Carter described optimum conditions of the latex agglutination test to 
detect Tipula iridescent virus (TIV) infection in the host insect. 
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Likar (1971) reported using the latex agglutination test to detect 
eastern encephalitis, St. Louis encephalitis, dengue II, and Cache Valley 
antibodies in human and animal sera. The LAT and hemagglutination-inhi-
bition tests gave similar results in the detection of the above arbovirus 
antibodies. 
Hechemy et al. (1974) reported that the latex agglutination test 
might have an application in E. coli serotyping. They found a LAT could 
detect as little as 0.5 ng of various E. coli extracts which made the test 
100 to 1000 times more sensitive than the standard bacterial agglutination 
test. No LAT cross-reactivity was observed among several E. coli sero­
types or with eight other genera of bacteria. 
Morton (1962) was the first to report the use of the LAT to detect 
specific mycoplasma antibodies. More extensive work by Morton (1966) 
indicated that the LAT detected antibodies in sera from rabbits hyper-
immunized with various mycoplasmas sooner than agar-gel diffusion or 
growth inhibition tests. 
Jain et al. (1969) used a bovine mycoplasma capable of causing 
mastitis in cows to evaluate the LAT. He found mycoplasma mastitis in­
fected herds exhibited a high percentage of latex positive animals. Anti­
bodies in experimentally infected cows and vaccinated rabbits were de­
tected much earlier with the LAT than with plate agglutination or agar-gel 
double diffusion tests. 
Kende (1969) evaluated the LAT for detecting M. pneumoniae antibodies 
in hyperimmune serum from guinea pigs, monkeys, rabbits, and in sera from 
humans naturally infected with M. pneumoniae. He found that the LAT de-
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tected antibodies in guinea pig or monkey hyperimmune serum as early as 
the CF test. Rabbit hyperimmune sera were found to need a trypsin-
periodate treatment to remove nonspecific agglutinins before the LAT gave 
interpretable reactions. Unfortunately, this treatment did not remove 
nonspecific agglutinins in sera from humans naturally infected with ^ 
pneumoniae. Thus, Kende postulated the LAT was limited to evaluating M. 
pneumoniae vaccines and could not be used for diagnosis of human M. pneu­
moniae infection. 
Gois et al. (1972) found detectable LAT titers to M. hyorhinis in 
sera from gnotobiotic pigs challenged with the organism. These titers 
were first detected as early as 1 week post-inoculation. Both mercapto-
ethanol treatment of the sera and chromatographic separation of the sera 
on Sephadex G 200 revealed that IgM was the antibody class participating 
in the latex agglutination reaction. 
Much early work utilizing the LAT with various organisms and antigens 
has not been adequately evaluated by subsequent workers because of lack of 
success with the test or the rapid development of other techniques that 
replaced the LAT. Studies in this category included: 1) trichinosis and 
latex agglutination tests by Innella and Redner (1959) and Muraschi et al. 
(1962); 2) LAT with Brucella antigens by Fleck and Evenchik (1962); 3) 
diagnosis of thyroid disease with the LAT by Philp et al. (1962); 4) 
leprosy studies with LAT by Cathcart et al. (1961); and 5) LAT for anaer­
obic diphtheroids by Florman and Scoma (1960). 
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Serologic Tests for Diagnosis of 
Mycoplasma hyopneumoniae Swine Pneumonia 
Boulanger and L'Ecuyer (1968) evaluated the di-ert, modified direct, 
and indirect complement-fixation (CF) tests as diagnostic tests for Myco­
plasma hyopneumoniae swine pneumonia. The direct test proved unsatis­
factory due to procomplementary effect of test swine sera, anti-comple-
mentary nature of the M. hyopneumoniae CF antigen, loss of CF titers upon 
heating test sera 56°C for 30 minutes, and the presence of natural hemo­
lysins in the test sera. The indirect CF test overcame some of these 
problems and gave low CF titers using sera from M. hyopneumoniae experi­
mentally infected pigs. By modifying the direct CF test with the addition 
of 1% fresh, unheated calf serum to the test system, Boulanger and 
L'Ecuyer found CF antibodies to M. hyopneumoniae could be detected in 
heat-inactivated sera from pigs challenged with the organism. These CF 
titers first appeared 14 to 21 days post-challenge and lasted from 1 to 9 
months. 
A second modified, direct tube CF test using a calf serum supplement 
was reported by Takatori et al. (1968). These workers reported that by 
using a modified CF test and by balancing the procomplementary activity of 
the test swine sera against the anti-complementary activity of the CF 
antigen, pigs artificially inoculated with M. hyopneumoniae broth cultures 
developed CF titers 2 to 3 weeks post-inoculation. Additional work re­
vealed no CF cross-reactions among various swine mycoplasmas including M. 
hyopneumoniae, Acholeplasma granularum (formerly M. qranularum), and M. 
hyorhinis. Chemical fractionation of M. hyopneumoniae demonstrated that 
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the CF antigen was found in both ether soluble and ether insoluble frac­
tions of the organism, and that the CF antigen was trypsin and heat 
stable. 
English workers, including Roberts (1968), attempted to develop a CF 
test using unheated test sera. Although a good correlation was found be­
tween high CF titer sera and pneumoniclesions, the test was restricted to 
sera with a 1:40 or greater CF titer. This was presumably due to natural 
hemolysins present in the sera and procomplementary effect of the test 
swine sera which resulted in 100% hemolysis of sensitized sheep red blood 
cells at dilutions of test swine sera of 1:40 or less. 
In an evaluation of modified CF tests using calf serum supplements to 
test for M. hyopenumoniae antibodies. Wall is and Thompson (1969) reported 
that modified CF tests failed to give demonstrable CF titers in infected 
pigs. In addition, they found dilutions of calf serum up to 1:1280 or 
greater fixed complement nonspecifically. They found, like Roberts, that 
a direct, unmodified CF test using unheated sera would detect antibodies 
in M. hyopneumoniae infected pigs at dilutions of 1:40 or greater. Thus, 
Wall is and Thompson concluded that M. hyopneumoniae CF antibodies were 
heat labile. 
In response to the work of Wall is and Thompson, Boulanger and 
L'Ecuyer (1970) reported that fresh serum from certain calves did fix 
complement nonspecifically in the presence of M. hyopneumoniae. Thus, it 
was necessary to pretest potential donor calves. Furthermore, Boulanger 
and L'Ecuyer stated that serum from 6-week-old calves that Wall is and 
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Thompson used would not possess adequate amounts of the supplementary 
factor for use in the CF test because the calves were too young. 
A direct microtiter CF test developed by Hodges and Betts (1969) re­
vealed a low degree of CF cross reaction between M. hyopneumoniae and 
Acholeplasma qranularum. This was in disagreement with most other 
workers, including Boulanger and L'Ecuyer (1968) and Takatori et al. 
(1968), who found no CF cross-reactions among various swine mycoplasmas. 
Slavik and Switzer (1972) developed a modified, microtiter CF test 
that permitted testing of swine sera that had been heated at 56°C for 30 
minutes for the presence of M. hyopneumoniae antibodies. By reconstitut­
ing the desiccated guinea pig serum for complement with normal swine sera 
and using heated test sera, they found the CF test detected M. hyopneu­
moniae antibodies at dilutions of test sera as low as 1:4. Experimentally 
M. hyopneumoniae broth culture inoculated pigs developed CF titers by 2 
to 4 weeks post-challenge and maintained detectable levels up to 20 weeks. 
Contact exposed pigs developed titers 5 to 13 weeks post-contact. Diethyl 
aminoethyl (DEAE) cellulose treatment of post-challenge sera indicated 
that the CF antibodies were of the 7S class. 
To examine the possibility of an auto-immune mechanism in the patho­
genesis of M. hyopneumoniae induced pneumonia of swine, Roberts and Little 
(1970) attempted to use a heated extract from a normal pig lung as a CF 
antigen. Of 400 swine sera tested in a conventional CF test using M. 
hyopneumoniae as the CF antigen, they found 40 CF positive sera. In a 
retest of the 400 samples in a CF test using the lung extract as the CF 
antigen, 17 of the 40 samples positive in the conventional test were found 
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to be CF positive in the second test. These 17 samples represented the 
sera that had the highest CF titers in the original CF test. The re­
maining samples were found to be negative in the lung extract CF test. 
Thus, Roberts and Little postulated that an auto-immune response might 
play a role in the pathogenesis of M. hyopneumoniae swine pneumonia. 
Because Takatori (1969) found that the CF test using M. hyopneumoniae 
strain 11, isolated by Mare and Switzer (1965) in Iowa, could detect anti­
bodies in field cases of swine pneumonia in Japan, he concluded that this 
strain was probably the cause of mycoplasmal swine pneumonia in Japan. 
Lam and Switzer (1972) used a sodium lauryl sulfate extract of M. 
hyopneumoniae as the antigen in an indirect hemagglutination (IHA) test. 
M. hyopneumoniae inoculated pigs developed IHA titers 2 to 3 weeks post-
inoculation. These titers reached maximal levels in 7 to 28 weeks and 
persisted up to 47 weeks post-inoculation. Field studies by Lam and 
Switzer (1971a) revealed 68% of the pigs with macroscopically normal 
appearing lungs exhibited IHA titers. Whether these pigs were lesionless 
carriers of M. hyopneumoniae, pigs recovered from the pneumonia but still 
possessing IHA antibodies, or false positives was not determined. 
A comparison of the IHA and CF tests by Goodwin et al. (1969) indi­
cated IHA titers were manifested later in the course of M. hyopneumoniae 
infection in swine, but were of longer duration. Both tests correlated 
well with presence or absence of lung lesions. Additional work by 
Goodwin and Hodgson (1970) demonstrated antibodies to M. hyopneumoniae in 
swine pneumonia tissues and bronchial lymph nodes could be detected by 
the IHA test. 
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Unlike Lam and Switzer (1971a), Holmgren (1974a) found that the IHA 
test gave only 3% positives in sera from pigs possessing normal appearing 
lungs, while in slaughter pigs with macroscopic and microscopic signs of 
mycoplasmal swine pneumonia, 89% of the pigs were IHA positive. Holmgren 
(1974b) found no IHA titers present in 2 to 5 weeks old pigs with pneu­
monia, while over 80% of the 10 weeks or older pigs with pneumonia showed 
IHA titers. 
Field evaluation of the IHA test by Gois as quoted by Whittlestone 
(1973) also indicated little problem with unexplained positives. Five 
swine herds believed free of mycoplasmal pneumonia had less than 2% IHA 
positives, while in six herds with a mycoplasmal pneumonia problem over 
50% of the pigs were IHA positive. 
Immunofluorescent staining to identify Mycoplasma hyopneumoniae in 
pneumonic lungs of pigs was first used by L'Ecuyer and Boulanger (1970). 
Specific fluorescence was first detected 25 days post-M. hyopneumoniae 
inoculation and lasted up to 49 days post-challenge. Fluorescent staining 
was almost entirely localized on the surface of the bronchial and bron-
chiolar epithelium and in bronchial exudates. Nonspecific staining was 
overcome by using the globulin fractions of serum from experimentally M. 
hyopneumoniae infected pigs for the fluorescein-serum conjugates instead 
of rabbit hyperimmune serum. In a small percentage of infected pigs lack 
of adequate numbers of M. hyopneumoniae organisms in the lung to join with 
the fluorescein-hyperimmune serum conjugate resulted in false negative 
FA results. Their work was confirmed by Meyling (1971). 
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Fujikura et al. (1970) developed a tube agglutination test for the 
detection of M. hyopneumoniae antibodies in the sera of infected pigs. By 
mixing concentrated antigen and dilutions of pig serum, incubating 2 hours 
at 37°C, followed by incubation at 4°C for 18 hours, they found macro­
scopic agglutination in all sera from pigs inoculated with M. hyopneu­
moniae. 
Pijoan and Boughton (1974), however, reported that Fujikura's method 
and other tube agglutination tests they conducted gave no agglutination 
titers using sera from pigs challenged with M. hyopneumoniae. Only when 
pigs were hyperimmunized with M. hyopneumoniae were any agglutination 
titers observed. 
Keusters-Klasens^ reported the use of a rapid serum plate test (RSPT) 
for the detection of M. hyopneumoniae antibodies in pig serum. By mixing 
test serum from pigs challenged with M. hyopneumoniae, M. hyopneumoniae 
fractionated antigen, and a latex solution on a glass slide, a visible 
agglutination occurred after 2 minutes. Experimentally infected pigs were 
found to develop RSPT titers 2 to 3 weeks post-M. hyopneumoniae inocula­
tion. These titers were found to last longer than 40 weeks post-inocula­
tion. In a comparison of the CF test and RSPT test, these workers found 
that the RSPT test was more sensitive in identifying infected swine than 
was the CF test. A greater percentage of nonspecific positives, however, 
was found with the RSPT than with the CF test. 
^M. Keusters-Klasens, Intervet International B.U., Boxmeer, the 
Netherlands. The use of a rapid serum plate test (RSPT) antigen for the 
detection of Mycoplasma hyopneumoniae antibodies in pig serum. Personal 
communication, 1973. 
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Roberts (1973) reported that tests for eel 1-mediated immunity might 
have some value in diagnosing M. hyopneumoniae swine pneumonia. Blood 
lymphocytes from pigs inoculated intratracheally with M. hyopneumoniae 
were found to have increased uptake of tritiated thymidine in the presence 
of M. hyopneumoniae organisms. Pigs infected with the organism gave posi­
tive intradermal reactions by 24 hours post-inoculated of M. hyopneu­
moniae. Roberts also adapted indirect macrophage inhibition test tech­
niques to demonstrate M. hyopneumoniae infection in swine. 
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MATERIALS AND METHODS 
Test Organism 
Mycoplasma hyopneumoniae strain VPP #11 was used in this study as the 
source of complement-fixation antigen, latex agglutination antigen, and as 
experimental inoculum. Huhn (1968) gave a complete history of this myco­
plasma. Briefly, L'Ecuyer (1962) isolated an infectious agent from con­
solidated apical and cardiac lobes of a pneumonic swine lung. The agent 
was cultivated in cell-free medium and was capable of producing pneumonia 
in pigs by intranasal inoculations (Mare, 1965). After further study and 
characterization of the agent by Mare and Switzer (1965), they proposed 
the name Mycoplasma hyopneumoniae. 
Broth Culture Medium 
Mycoplasma hyopneumoniae was grown in cell-free media consisting of 
Eagles balanced salts, yeast extract, lactalbumin hydrolysate, HEPES 
buffer, and swine sera. Preparation of individual components of the 
medium was as follows: 
A. Preparation of acid adjusted swine serum 
1. Pooled swine serum was heat inactivated at 56°C for 30 minutes. 
2. IN HCl was added until pH of heat inactivated swine sera was 
between 4.3 and 4.5. 
3. Swine sera was then centrifuged at 650 g (2000 rpm. International 
Model V centrifuge with 976 head) for 15 minutes. Sediment was 
discarded. 
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4. Serum was clarified through Whatman GF/A fiberglass filter pad 
and Selas #10, #01, #015, and #02 porcelain filters. 
5. The pH of filtered serum was adjusted to pH 7.0 with IN NaOH and 
frozen at -20°C until used. 
B. Preparation of yeast extract (Hayflick, 1965) 
1. Two-hundred fifty grams Fleischmann's type 20-40 dry yeast^ were 
added to 1 liter of ion exchange water. 
2. The mixture was heated to boiling, with constant stirring. 
3. The yeast mixture was then filtered through two sheets of Whatman 
#1 filter paper or through Whatman GF/A fiberglass filter pads. 
4. IN NaOH was added to adjust the pH adjusted to 8.0. If mixture 
was not clear after this step, it was discarded. 
5. Yeast mixture was then dispensed in 7 to 8 ml aliquots and auto-
claved at 251°F for 15 minutes. The precipitate formed after 
autoclaving was not used in medium. 
6. The sterile yeast extract was stored at -20°C until used. 
2 C. Enzymatic lactalbumin hydrolysate was of tissue culture grade. 
D. Eagles medium used was Eagle's Minimum Essential Medium in 9,8 gram 
3 portions per package. Phenol red was present in medium as pH indi­
cator. 
^Standard Brands Inc., New York, New York. 
^Nutritional Biochemical Corporation, Cleveland, Ohio. 
O 
Grand Island Biological Company, Grand Island, New York. 
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E. HEPES buffer (N-2 hydroxyethyl piperazine-N2 ethane sulfonic acid) was 
added as an additional bufferJ 
The complete Eagle's broth medium was prepared by combining the fol-
owing components. 
1. 1200 ml ion exchange water 
2. 11.76 gm Eagle's Minimum Essential Medium 
3. 7.152 gm HEPES buffer 
4. 12.0 ml yeast extract 
5. 300 ml acid adjusted swine serum 
6. 12.0 gm enzymatic lactalbumin hydrolysate 
The pH of the medium was adjusted to pH 7.6 with IN NaOH and filtered 
through a Herman filter #D5 clarifying pad and a #D8 sterilizing pad. The 
growth medium was dispensed in approximately 500 ml portions into each of 
three sterilized 1 liter screw top flasks or in 4.5 ml aliquots into 
sterilized screw top glass tubes. As a sterility check the medium in the 
tubes and flasks was incubated at 37°C for 24 hours. The flask medium was 
then inoculated with M. hyopneumoniae broth cultures. The tube medium 
could be stored up to 8 weeks at 4°C before inoculation. 
Solid Medium 
Eagle's complete broth medium was prepared as described above except 
600 ml of ion exchange water was used instead of 1200 ml. This resulted 
in a 2X stock solution of medium. The solid Eagle's agar medium was 
^Nutritional Biochemical Corporation, Cleveland, Ohio. 
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prepared by the following procedure: 
1. 3.6 gm Oxoid Ion Agar #2^ was added to 200 ml ion exchange water 
and heated until agar dissolved. 
2. The agar solution was autoclaved for 15 minutes at 251°F and 
cooled in a 45°C water bath. 
3. 300 ml of Eagle's 2X stock solution with swine serum was mixed 
with 200 ml of agar solution at 45°C. 
4. The complete Eagle's agar medium was dispensed in approximately 
6 ml aliquots into 60 x 15 mm plates. 
Preparation of LAT and CF Antigens 
Six screw top flasks containing approximately 500 ml of complete 
Eagle's medium were each inoculated with 25 ml of a 3 day broth stock 
culture of M. hyopneumoniae passage 130 to 160. The culture had been 
frozen at -20°C in complete Eagle's medium containing a final concentra­
tion of 12% sucrose (sucrose was added to reduce loss of viability of M. 
hyopneumoniae during freezing and thawing). The flasks were incubated at 
37°C in a shaking water bath set at approximately 15 oscillations per 
minute. The flask cultures were harvested when the pH of the medium fell 
from 7.6 to 6.7 to 6.8 as judged by the change in color of the phenol red 
indicator. This was usually 3 to 6 days post-inoculation. At the time of 
the flask culture harvest, 5 ml of broth culture was asceptically removed 
for use in contamination checks and growth initiation titrations. The 
^Oxoid Limited, London, England. 
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organisms in the broth culture flasks were fir.it concentrated by centrifu-
gation at 12,000 rpm (15,000 x g) for 45 minutes in a Beckman Model L-2-65 
preparative ultracentrifuge. The centrifugate was reconstituted to 12 ml 
with veronal buffer diluent (VBD) and centrifuged at 2500 rpm (1300 x g) 
for 45 minutes in 15 ml graduated glass centrifuge tubes. The resulting 
centrifugate was reconstituted to a 1:40 concentration with VBD, dispensed 
in 5 ml aliquots, and stored at -20°C. Prior to titration in the CF or 
latex tests, M. h.yopneumoniae suspensions were put through a hand homoge-
nizer^ to break up aggregates of organisms. 
Growth Initiation Titers 
Five-tenths ml of flask culture was inoculated into 4.5 ml of com­
plete Eagle's medium. Continuing tenfold dilutions of inoculum were made 
until a final dilution of 10"^" of inoculum was obtained. Incubation was 
at 37°C for 2 weeks. Growth of M. hyopneumoniae was determined by pH 
change (as indicated by phenol red color change) and turbidity. A growth 
initiation titer of 10"® or greater by 1 week usually correlated with the 
harvested M. hyopneumoniae being high titered CF and LAT antigens. 
Preparation of Veronal Buffered Diluent (VBD) 
A 5X stock solution of VBD was prepared by combining the following 
components in a 2 liter volumetric flask; 
^Scientific Products, Evanston, Illinois. 
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1. NaCl 83.00 gm 
2. Na-5, 5-cliethyl barbiturate 10.19 gm 
3. Distilled water 500.00 ml 
4. IN HCl 30.00 ml 
5. Stock solution containing 
1 molar MgClg and 0.3 molar 
CaClg (20.3 gm MgClg-GHzO 
and 4.4 gm CaCl2*2H20 in 
100 ml distilled water) 
5.0 ml 
The flask was filled to mark with distilled water and mixed thorough­
ly. This 5X stock VBD was stored at 4°C for as long as a month. A IX 
VBO was made by adding 100 ml of the stock VBD to 400 ml distilled water. 
Sixteen ml of 2.5% gelatin was added to the 500 ml of IX VBD. The IX VBD 
with gelatin was stored at 4°C. 
Glycine buffered saline was prepared by adding 2.925 gm of NaCl and 
3.7525 gm of glycine to 500 ml ion exchange water. The pH was then ad­
justed to 8.2 with IN NaOH. Before used in the LAT, 1 ml of 5% bovine 
serum albumin was added per 100 ml GBS. 
Experimental pigs used in this study were obtained from a surgically 
derived herd founded in 1951 and maintained to the present time at the 
Veterinary Medical Research Institute. Other than occasional additions 
Glycine Buffered Saline (GBS) 
Experimental Pigs 
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of surgically derived pigs for genetic purposes, the herd has remained 
isolated from other swine since its inception. 
Hemophilus suis and parasuis were detected for the first time in 1967 
and were present in the herd at the time of these experiments. Bordetella 
bronchiseptica was first detected in the herd in 1970. Removal of all B. 
bronchiseptica positive pigs as indicated by nasal swabbing culture tech­
niques resulted in the herd becoming B. bronchiseptica-free in 1973. 
Mycoplasmal pneumonia was first demonstrated in the herd in 1970 by the CF 
test and presence of gross pneumonic lesions. Intensified CF testing and 
removal of all CF positive animals resulted in a CF negative herd until 
1975. At that time, several CF positive animals were detected and gross 
pneumonic lesions were found. In the final stages of the present study, 
CF testing of the herd was intensified and all CF positive animals were 
immediately removed. 
Pigs in this herd were maintained on a drug and antibiotic-free 
ration. 
Experimental Inoculations of Pigs 
Eight to 10 weeks old Yorkshire and Hampshire pigs were inoculated 
intranasally or intratracheally with 1.0 ml of a 3 day broth culture of 
M. hyopneumoniae or a 20% suspension of homogenized pneumonic lung in 




Blood was drawn from experimental pigs via anterior vena cava. The 
collected blood was placed at 4°C for 1 to 4 hours to clot and then 
centrifuged at 1700 rpm (600 x g) for 20 minutes. The sera was aspirated 
after centrifugation and frozen at -80°C until tested. 
Preparation of Lung Sections for Microscopic Examination 
At necropsy, sections of lungs were taken from each pig and placed in 
10% formalin. The formalin fixed lung sections were then trimmed and 
embedded in Paraplast tissue-embedding medium. Sections were cut at 6 
micron thickness, mounted on glass slides with an albumin fixative, and 
stained with Harris' hemotoxylin and counterstained with eosin. 
Mycoplasma hyopneumoniae Isolation 
At necropsy, portions of each pig lung were asceptically removed and 
placed in a sterile container. The lung portions were either processed 
immediately or frozen at -20°C for future attempts to isolate M. hyopneu­
moniae. The portions of lung used for isolation attempts were ground in a 
TenBroeck grinder with complete Eagle's medium containing 1000 I.U./ml of 
penicillin and 1:10,000 dilution of thallium acetate. Five-tenths ml of 
pneumonic lung suspension was inoculated into 4.5 ml of complete Eagle's 
medium, also containing penicillin and thallium acetate. Continuing ten­
fold dilutions were made until the final concentration of 10"** of lung 
suspension was reached. Subculturing was done with each tube at 4 to 6 
day intervals. Incubation of all tubes was at 37°C. Subculturing was 
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continued for 3 weeks. Positive isolation was determined by pH change, 
turbidity, morphology of colonies on solid Eagle's medium, Giemsa stain­
ing, and lack of growth on blood agar, thioglycolate broth,^ and beef 
heart infusion-turkey serum plates or in beef heart infusion-turkey serum 
broth (Ross and Karmon, 1970). 
Complement Fixation Test 
A direct micro-complement fixation test developed by the Laboratory 
Branch of the Communicable Disease Center (1965) and modified by Slavik 
(1971) was used in the course of this work. A 50% hemolytic unit of com­
plement, a plateau method of titering hemolysin (Osier et al., 1952), and 
a block titration of antigen formed the basis of the test. Briefly, the 
test reagents were prepared for titrations in the following manner: 
1. Lyophilized guinea pig complement (GPC)^ was reconstituted with 
normal swine sera and titered in serological test tubes (10 mm x 
85 mm). Five units of complement were employed in the diagnostic 
test. 
2. A 1:40 Mycoplasma hyopneumoniae suspension was prepared as pre­
viously described. This suspension was heated 52°C for 30 min-
2 
utes and titered in plastic microtitration plates against a 
known M. hyopneumoniae positive control serum. The highest dilu­
tion of antigen exhibiting acceptable anti-complementary levels 
^Difco Laboratories, Detroit, Michigan. 
2 Linbro Chemical Company, Inc., New Haven, Connecticut. 
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and giving the greatest fixation of complement with the highest 
dilution of antiserum was chosen as the concentration of 
diagnostic antigen. 
3. Rabbit anti-sheep hemolysin^ was titered and stored at -20°C in 
1 ml aliquots of a 1:100 dilution. 
4. Veronal buffered diluent was prepared as previously described and 
used as the diluent in the CF test. 
5. Test swine sera were heated 56°C for 30 minutes before titration 
in the test. 
Briefly, the diagnostic CF test involved adding chilled GPC reconsti­
tuted with normal swine serum and antigen to serum dilutions in microti-
tration plates. The plates were kept at 4°C for 16-18 hours before adding 
sensitized sheep RBC. After 30 minutes incubation at 37°C, the plates 
were centrifuged and the percent hemolysis recorded. A serum exhibiting 
0 to 30% hemolysis was considered positive, greater than 30% to 70% was 
suspicious, and more than 70% hemolysis was considered negative for M. 
hyopneumoniae antibodies. 
Latex Agglutination Test (LAT) 
The latex agglutination test developed by Morton (1966) was modified 
and evaluated as a serological test for diagnosis of Mycoplasma hyopneu­
moniae swine pneumonia. The preparation of reagents for use in the LAT 
was as follows: 
^Difco Laboratories, Detroit, Michigan. 
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1. Glycine buffered saline was prepared as earlier described and 
used as the diluent, 
2. Bovine serum albumin Fraction V (BSA)^ was prepared by adding 
1 gm BSA to 5.0 ml deionized water and mixing. 
3. Test swine sera were heated at 56°C for 30 minutes. 
4. Twofold dilutions of a 1:40 suspension of M. hyopneumoniae were 
made in GBS to a final concentration of 1:320. Each dilution was 
2 
sonicated for 30 seconds in a Bronwill Biosonik sonicator set at 
maximum probe intensity. The sonicated antigens were heated 52°C 
for 30 minutes prior to titration. 
O 
5. Latex of a 0.81 y particle diameter was diluted 1:5 in deionized 
water and stored at 4°C. 
A latex-M. hyopneumoniae complex for use in antigen titrations and 
diagnostic tests was prepared by adding 0.4 ml of a 1:5 latex suspension 
to a 1 ml suspension of sonicated and heated M. hyopneumoniae. After 
incubation at room temperature for 10 minutes, 8.6 ml GBS with BSA was 
added. Following 10 more minutes incubation at room temperature, the 
antigen sensitized latex suspension was used in antigen titrations or 
diagnostic tests. 
^Reheis Chemical Company, Chicago, Illinois. 
2 Bronwill Scientific, Rochester, New York. 
Difco Laboratories, Inc., Detroit, Michigan. 
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A positive control serum from a pig infected with M. hyopneumoniae 
was used to titer the LAT antigen. The antigen titration was done in 
85 X 10 mm serological test tubes using a checkerboard titration by the 
following procedure: 
1. One ml of positive control serum was diluted in GBS with BSA in 
twofold dilutions to a final concentration of 1:256. 
2. A 0.25 ml quantity of each dilution was added to each of three 
serological test tubes. The result was four sets of serum dilu­
tions from 1:2 to 1:256. 
3. To the first set of serum dilutions 0.25 ml of a 1:40 antigen 
sensitized latex was added to each tube. The second set of serum 
dilutions received 0.25 ml of 1:80 antigen sensitized latex. 
This procedure was repeated for the remaining two sets of serum 
dilutions, with the fourth set receiving 0.25 ml of a 1:320 
antigen sensitized latex preparation. The tubes were shaken in 
the rack by hand for approximately 30 seconds and incubated at 
40°C for 1 hour. The tubes were then centrifuged at 2000 rpm 
(650 X g) for 10 minutes. 
Each tube was observed for presence of turbidity in the supernatant 
and then shaken two or three times by hand until the sediment was resus-
pended. A serum sample that caused a clear supernatant and large parti­
cles after being shaken was regarded as a strong positive and graded as a 
3+. A sample that had slight turbidity and smaller, but still discrete 
particles was graded as a 2+ positive. Samples that had fairly turbid 
supernatants and particles that would go into suspension after four or 
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five additional shakes were regarded as suspicious and graded 1+. A 
sample that had a turbid supernatant and no agglutination was regarded as 
negative. 
This procedure was repeated with a negative control serum at the same 
time. Tubes containing latex and serum but no antigen, and tubes con­
taining latex and antigen but no antiserum were included as controls. 
The dilution of antigen that gave the strongest agglutination with 
the highest serum dilution was chosen as the concentration of diagnostic 
antigen provided all controls were acceptable. 
The diagnostic latex agglutination test was done by adding 0.25 ml 
of the appropriate dilution of antigen sensitized latex (as determined by 
above antigen titration method) to 0.25 ml of test serum dilution from 
1:8 to 1:128. Dilutions of serum of 1:2 and 1:4 were used as controls and 
received 0.25 ml of nonantigen sensitized latex. Incubation conditions 
were 40°C for 1 hour. The tubes were then centrifuged at 2000 rpm (650 x 
g) for 10 minutes, and agglutination recorded in the same manner as de­
scribed in antigen titration. 
Development of Latex Agglutination Antibodies Against 
M. hyopneumoniae in Experimentally Inoculated Pigs 
Experiment 1_ 
Three LAT negative 6 weeks old pigs (Nos. 1, 2, 3) were intranasally 
inoculated on 2 consecutive days with 5 ml of a 2 day broth culture of the 
23rd passage of M. hyopneumoniae. The pigs were bled at weekly intervals 
for 15 weeks post-inoculation and necropsied at 24 weeks post-inoculation. 
At necropsy, the lungs were examined for gross signs of pneumonia. 
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Experiment 2 
Six LAT negative 6 to 8 weeks old pigs (Nos. 4-9) were given three 
intratracheal inoculations in a 2 week period with 1 ml of a 20% M. hyo-
pneumoniae pneumonic lung suspension in complete Eagle's medium. The pigs 
were bled at 2 and 3 weeks after the first inoculation and necropsied on 
the fourth week post-first inoculation, at which time the lungs were 
examined for gross lesions and sections were taken for microscopic exami­
nation. 
Development of LAT Antibody in Contact Exposed Pigs 
Three 6 weeks old pigs (Nos. 1, 2, 3) received 5 ml intranasal inocu­
lations on 2 consecutive days of a 2 day broth culture of the 23rd passage 
of M. hyopneumoniae. Three additional 6 weeks old pigs (Nos. 10, 11, 12) 
housed in the same isolation unit received no inoculations. All pigs were 
bled weekly for 15 weeks and necropsied at 24 weeks, at which time the 
lungs were inspected for gross pneumonia. 
Correlation of Latex Agglutination Titers and Protection 
Against M. hyopneumoniae Contact Exposure 
Experiment 1 
Eighteen LAT and CF negative 6 week old pigs (Nos. 30-47) were di­
vided into groups of six and put into three isolation units. One group 
(Nos. 36-41) received an intratracheal inoculation of 2 ml of a 20% M. 
hyopneumoniae pneumonic lung suspension in complete Eagle's medium. The 
inoculations were repeated on the 7th and 13th day. Another group of six 
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pigs (Nos. 42-47) received intratracheal inoculations of 2 ml of a 1:40 
M. hyopneumoniae suspension in veronal buffer diluent on days 1, 7, and 
13. The suspension was heated 1 hour at 52°C prior to inoculation. The 
remaining group of six pigs (Nos. 30-35) received no treatment. On day 
18, two pigs from each of the three groups were mixed and put into isola­
tion units. All 18 pigs were bled weekly throughout the course of the 
experiment. On day 52, six pigs (Nos. 33, 35, 36, 41, 44, 46) from one 
isolation unit were necropsied, while on day 87 the remaining 12 pigs were 
necropsied. Lungs were examined for gross signs of pneumonia. 
Experiment ^ 
Six 7 to 8 weeks old pigs (Nos. 13-18) received the following three 
treatments: 1) 3.0 ml fluid culture of passage 131 M. hyopneumoniae 
intravenously; 2) 0.3 ml of an equal volume of a 1:10 M. hyopneumoniae 
suspension in VBD heated 52°C for 30 minutes and Freund's incomplete 
adjuvant into the left front footpad; and 3) same as 2 except 1.0 ml in­
jected into the flank. These inoculations were repeated at 6 days. A 
control group of 8 pigs (Nos. 19-26) received no treatments. Three weeks 
post-treatments all pigs were inoculated intranasally with 1 ml of a 1% 
M. hyopneumoniae lung suspension in complete Eagles medium. Five weeks 
post-inoculation all pigs were necropsied and their lungs were examined 
for evidence of pneumonia. Blood samples were collected periodically 
during the experiment. 
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Duration of Latex Agglutination, Complement Fixation, and Indirect 
Hemagglutination Titers of M. hyopneumoniae Inoculated Swine 
The LAT and CF tests were used to titer post-infection sera^ from 
three pigs (Nos. 51, 52, 53) that had received intranasal inoculations of 
5 ml of a 3 day broth culture of the 23rd passage of ^ hyopneumoniae on 
2 consecutive days. The duration of CF and LAT titers were then compared 
with the duration of IHA titers.^ 
Diethyl aminoethyl (DEAE) Cellulose^ Treatment of Sera 
To determine if the class of antibody detected by the LAT was 7S or 
19S, post-inoculation sera from two pigs (Nos. 51, 53) experimentally 
inoculated with a broth culture of the 23rd passage of M. hyopneumoniae 
were treated with DEAE cellulose using the batch adsorption of Stanworth 
(1960). The sera were then retitered in the LAT. 
2-Mercaptoethanol Treatment of Sera 
Pre-inoculation sera and post-inoculation sera from three pigs (Nos. 
51, 52, 53) experimentally inoculated with the 23rd passage of M. hyo­
pneumoniae were treated with 2-mercaptoethanol as described by Hogle 
(1967). Sera containing a final concentration of 0.05 molar 2-mercapto­
ethanol were incubated at 25°C for 4 hours. The samples were then 
^Sera and IHA titers were obtained from Dr. Kenneth Lam, Temple 
University, Philadelphia, Pennsylvania. 
p Schleicher and Schuell, Keene, New Hampshire. 
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dialyzed 24 hours against pH 7.2 phosphate buffered saline containing 
0-02 M iodoacetatnide and titered in the LAT. 
Repeatability of Latex Agglutination Test Results 
Five sera from pigs (Nos. 231, 232, 287, 289, 503) exhibiting normal 
appearing lungs at necropsy and ten post-inoculation sera from pigs (Nos. 
36-41, 1-4) that had been experimentally inoculated with either M. hyo-
pneumoniae fluid culture or M. hyopneumoniae pneumonic lung suspensions 
and had pneumonic lungs at necropsy were divided into 4 aliquots and 
stored at -70°C. On 4 successive weeks 1 set of aliquots was titered in 
the LAT. 
Specificity of Latex Agglutination Test 
for hyopneumoniae Antibodies 
Experiment 1_ 
To determine if hyosynoviae or ^ hyorhinis infected pigs would 
give positive M. hyopneumoniae LAT results, five pre-inoculation sera and 
15 post-inoculation sera from M. hyosynoviae experimentally inoculated 
pigs^ (Nos. 142-146) and four pre-inoculation sera and 12 post-inoculation 
sera from M. hyorhinis experimentally inoculated pigs^ (Nos. 147-150) were 
titered in the M. hyopneumoniae latex agglutination test. 
'Sera were obtained from Dr. R. Ross, Veterinary Medical Research 
Institute, Iowa State University, Ames, Iowa. 
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Experiment 2 
Sera^ from three pigs (Nos. 151, 152, 153) infected with lungworms 
(Metastrongylus spp.) were titered in the M. hyopneumoniae LAT to deter­
mine if lungworm infection in pigs might give rise to antibodies that 
would cross-react in the M. hyopneumoniae LAT. 
Experiment _3 
To test the possibility that Ascaris suum infection of pigs might 
give rise to antibodies that would react in the M. hyopneumoniae LAT, 
sera^ from two pigs (Nos. 154, 155) experimentally infected with Ascaris 
suum were titered in the LAT. 
Experiment ^ 
To determine if pigs vaccinated with various commonly used vaccines 
would develop antibodies that would react in the M. hyopneumoniae LAT, 
five pigs each were given the following inoculations: T) Leptospira 
O A 
Canicola-icterohaemorragae Bacterin; 2) Erysipelas Bacterin Ersipelin; 
3) Porcine Mixed Bacterin #1;^ and 4) Porcine Mixed Bacterin #2.^ Post-
vaccination sera were then titered in the LAT. 
^Sera were obtained from Dr. K. Preston, Veterinary Medical Research 
Institute, Iowa State University, Ames, Iowa. 
^Inoculations were done by A. Harris, Veterinary Medical Research 
Institute, Iowa State University, Ames, Iowa. 
^Bio-Ceutic Laboratories, Inc., St. Joseph, Missouri. 
^Fort Dodge Laboratories, Inc., Fort Dodge, Iowa. 
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Attempts to Remove Nonspecific Agglutinins from Test Sera 
To remove possible nonspecific agglutinins in test swine sera, ten 
LAT positive sera from pigs (Nos. 492-501) showing no gross or microscopic 
lesions, five LAT negative sera from pigs (Nos. 502-506) having normal 
appearing lungs, and five LAT positive sera from pigs (Nos. 507-511) ex­
perimentally inoculated with M. hyopneumoniae broth cultures and having 
gross pneumonic lesions were divided into 2 aliquots and absorbed with 
equal volume of 5% sheep RBC for 5 hours at 4°C or absorbed with equal 
volume of 5% swine RBC for 5 hours. Following above procedures the sera 
were retitered in LAT. 
Effects on LAT Serum Titers of Various Physical and Chemical 
Treatments of ^ hyopneumoniae Antigen 
In the course of this study, M. hyopneumoniae was subjected to 
various chemical and physical treatments to obtain a LAT antigen that 
would be more specific for M. hyopneumoniae antibodies and yet give 
reasonably high LAT titers with sera from pigs infected with M. hyopneu­
moniae. After each physical or chemical treatment, the treated antigen 
was titered against a known CF and LAT positive serum from a pig (No. 3) 
experimentally inoculated with a broth culture of the 23rd passage of M. 
hyopneumoniae. If the antigen had any LAT activity, it was used to titer 
five CF and LAT negative sera from pigs (Nos. 502-506) having normal 
appearing lungs, and five CF and LAT positive sera from pigs (Nos. 4, 5, 
19, 51, 52) having gross M. hyopneumoniae pneumonic lesions. 
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Experiment 1 
A 1:20 suspension of M. hyopneumoniae in GBS was divided into 2 ml 
aliquots and treated as follows: 1) no treatment; 2) sonicated for 30 
seconds in a Biosonik sonicator^ at maximum probe intensity; 3) heated 
52°C for 30 minutes; 4) heated at 52°C for 30 minutes, then sonicated as 
above; and 5) sonicated as above, then heated for 30 minutes at 52°C. 
Experiment 2 
Five ml absolute methanol was added to 0.2 ml M. hyopneumoniae packed 
cells. The suspension was shaken and placed at 4°C for 1 hour before 
centrifugation at 1400 x g for 45 minutes. The supernatant was aspirated 
and air dried in a glass petri plate. The residue remaining after metha­
nol evaporation was reconstituted to 1.8 ml in GBS. The sediment remain­
ing after centrifugation was also reconstituted to 1.8 ml with GBS. Both 
reconstituted fractions were then titered in the LAT. The above procedure 
was repeated using chloroform and ether as the organic solvents. 
Experiment _3 
Two ml aliquots of a 1:20 suspension of M. hyopneumoniae were heated 
at the following temperatures: 1) 45°C for 30 minutes; 2) 65°C for 30 
minutes; and 3) 100°C for 30 minutes. Each heated antigen suspension was 
centrifuged at 1400 x g for 45 minutes. The supernatants were aspirated 
and the sediments were reconstituted with GBS to the original 2 ml volume. 
All supernatants and reconstituted sediments were checked for LAT antigen 
activity. 
^Fisher Scientific Company, Fair Lawn, New Jersey. 
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Experiment 4 
Four ml genetron 113 (trifluorotrichloroethane)^ were added to 4 ml 
of a 10% suspension of M. hyopneumoniae in GBS. The mixtures were hand 
shaken for 3 to 5 minutes and then centrifuged at 800 x g for 5 minutes. 
The aqueous layer was aspirated and tested for LAT activity. 
Experiment 5 
Four aliquots containing 4 ml of a 1:20 M. hyopneumoniae suspension 
in GBS with final concentrations of 2%, 1%, 0.5% and 0.1% trypsin^ re­
spectively were incubated at 37°C for 1 hour. The suspensions were then 
heated at 54°C for 60 minutes to inactivate the trypsin and centrifuged at 
1400 X g for 45 minutes. The supernatants were aspirated and the sedi­
ments were reconstituted to original 4 ml volume. The supernatants and 
reconstituted sediments were then checked for LAT activity. 
Field Evaluation of M. hyopneumoniae Latex Agglutination Test 
Ten Iowa Specific Pathogen Free (SPF) swine herds were used in this 
trial to evaluate the ability of the M. hyopneumoniae LAT to detect M. 
hyopneumoniae infection in swine. Seven to 10 lungs and serum samples 
3 from each herd were collected from 95 market weight pigs. The lungs were 
examined for gross pneumonia and sections were taken for microscopic 
^Allied Chemical Corporation, New York, New York. 
2 Difco Laboratories, Inc., Detroit, Michigan. 
3 Lungs and sera were collected by James McKean, Extension Veteri­
narian, Iowa State University, Ames, Iowa. 
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1 2 examination and M. hyopneumoniae isolation attempts. The serum samples 
were titered in the CF test and the LAT. A total of fifty additional 3 to 
9 weeks old pigs from these herds were also necropsied. The serum and 
lungs from these pigs were handled as above. 
Fifty sera and lungs were collected from pigs that entered Iowa State 
University's Veterinary Diagnostic Laboratory during a 3 month period. 
The lungs were examined for gross pneumonic lesions and the sera titered 
in the CF test and the LAT. 
Twenty-seven sera from 3 Nebraska SPF herds were titered in the LAT 
and the titers checked for correlation with available lung data and M. 
3 hyopneumoniae isolation attempts. 
One hundred and six sera from five additional Iowa SPF swine herds 
were tested in the LAT and CF test and correlated on a herd basis with 
microscopic lung data of penmates of tested pigs. 
One hundred and seven sera from additional swine herds located in 
Iowa, Texas, and California were titered in the LAT and CF test. All 
lungs from these pigs were examined microscopically for lesions typical of 
MPS. 4 
^Microscopic examinations were done by John Andrews, Iowa State 
University, Ames, Iowa. 
2 Attempted isolation of M. hyopneumoniae were done by Dan Farrington, 
Veterinary Medical Research Institute, Iowa State University, Ames, Iowa. 
O 
Examination of lungs and isolation attempts were done by E. L. 
Stair, Oklahoma State University and James Dunn, Texas Veterinary Medical 
Diagnostic Laboratory, Amarillo, Texas. 
^Microscopic lung examination was done by Veterinary Diagnostic 
Laboratory, Iowa State University, Ames, Iowa. 
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To test for nonspecific LAT serum titers, 36 sera from 8 month old 
pigs that had been CF negative on three previous CF tests and had been 
isolated from other swine, were titered in the LA and CF test. 
Twenty-eight sera from 3 months old pigs were titered in the CF test 
and LAT. These pigs were farrowed by CF negative sows and were from an 
Iowa SPF herd that passed slaughter checks for pneumonia. 
Serum samples were collected from 20 sows that had farrowed 6 to 8 
weeks earlier and from three pigs in each litter. The sera were titered 
in the LAT and correlated with lung data obtained after subsequent 
necropsy of the 20 sows. 
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RESULTS 
Development of Latex Agglutination Antibodies Against 
M. hyopneumoniae in Experimentally Exposed Pigs 
Experiment 1 
As shown in Figure 1, latex agglutination titers were first demon­
strated 2 weeks after M. hyopneumoniae inoculation in two of the pigs 
(Nos. 1 and 2), while in the third pig (No. 3) LAT titers were first de­
tected 3 weeks post-inoculation. At the termination of the experiment, 
24 weeks post-exposure, all three pigs had demonstrable LAT titers. An 
examination of the lungs revealed no evidence of gross pneumonic lesions. 
Experiment Z 
Five of six pigs (Nos. 4, 5, 6, 7, and 9) exhibited LAT titers 2 
weeks post-inoculation. The remaining pig (No. 8) developed a detectable 
titer 3 weeks post-inoculation (Table 1). Gross evidence of pneumonia was 
observed in lungs from four pigs (Nos. 4, 7, 8, and 9), while the lungs 
from the remaining two pigs (Nos. 5 and 6) appeared normal. Microscopic 
examination of lung sections revealed histopathological changes typical of 
MPS in lung sections from four pigs (Nos. 4, 7, 8, 9), while lung sections 
from one pig (No. 6) showed only slight histopathological changes and was 
considered suspicious for MPS. The lung from the remaining pig (No. 5) 
was normal. 
Pig No. 2 
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Figure 1. Development of post-inoculation LAT serum titers 
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Table 1. Development of LAT antibodies® 
experimentally inoculated pigs 
against M. hyopneumoniae in 
Weeks post-inoculation 
Pig No. 2 3 4 
4 32 64 128 
5 64 64 128 
6 8 16 32 
7 8 16 64 
8 <8 16 32 
9 8 16 32 
\l\l titers are reciprocals of highest serum dilution giving 
agglutination. 
Development of LAT Antibody in Contact Exposed Pigs 
As shown in Figure 2, demonstrable LAT titers were observed 4 weeks 
post-contact in one pig (No. 10), 5 weeks post-contact in another pig 
(No. 12) and 12 weeks post-contact in the remaining pig (No. 11). Gross 
examination of the lungs revealed mild scarring in the lungs of one pig 
(No. 10), an estimated 1% pneumonic lesions in the lungs of another pig 
(No. 12), and no lesions in the lungs of the remaining pig (No. 11). 
512 Pig No. 10 
Pig No. 11 
Pig No. 12 O—O—O— 5 256 
Ch 128 
32 
|Q-—I— It <8 
1 0  
Weeks Post-contact with M. hyopneumoniae Inoculated Pigs 
Figure 2. Development of LAT titers from contact with ^ hyopneumoniae inoculated pigs 
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Correlation of Latex Agglutination Titers and Protection 
Against M. hyopneumoniae Contact Exposure 
Experiment % 
The six pigs in the vaccinated group and the six pigs in the inocu­
lated group developed detectable LAT 3 weeks post-treatment. The inocu­
lated pigs had LAT titers at this time which were two-to-fivefold dilu­
tions lower than were the LAT titers of the vaccinates. The contact ex­
posed pigs first demonstrated LAT titers 1 month after exposure to the 
inoculated group. As shown in Table 2, all pigs had LAT titers at the 
time of necropsy with no appreciable differences in levels of titers among 
the three groups. In the inoculated group two pigs (Nos. 36 and 40) had 
typical M. hyopneumoniae lung lesions, two pigs (Nos. 37 and 39) had lungs 
containing resolving lesions, and the remaining two pigs (Nos. 38 and 41) 
of this group had normal appearing lungs. In the contact exposed pigs, 
only one pig (No. 32) had normal appearing lungs, while in the vaccinated 
group fourofsix pigs (Nos. 42, 43, 45, and 47) had normal appearing lungs. 
Experiment 2 
In five of six pigs (Nos. 13, 14, 15, 17 and 18) inoculated simul­
taneously with heat-inactivated M. hyopneumoniae by intravenous, footpad, 
and subcutaneous routes, LAT serum antibody was detected 7 days post-
inoculation. The remaining pig (No. 16) of this group developed a de­
tectable LAT titer by 19 days post-inoculation. As shown in Table 3, the 
LAT titers at necropsy ranged from 1:32 to 1:4096. Examination of the 
lungs revealed that the pig (No. 16) with the 1:32 LAT was the only one of 
the inoculated group that developed gross pneumonic lesions as a result of -
4/ 
Table 2. Correlation of latex agglutination titers and protection against 
M. hyopneumoniae contact exposure 
LAT titers 
Pig 3 wks post- At ne-
No. Treatment treatment^ cropsy Lungs 
30 Contact exposure to pigs 
inoculated with M. hyo­





<4 128 3°r 
<4 128 5% 
<4 16 Normal 
<4 32 5 to 7% 
<4 128 2% 








of 20% ^ hyopneumoniae 
pneumonic lung suspension 
32^ 16 2% 
16 32 Scarring 
16 8 Normal 
8 128 Scarring 
16 128 5% 
16 128 Normal 
42 Intratracheal inoculations 128 32 Normal 
43 of 1:40 M. hyopneumoniae 32 64 Normal suspension in VBD. Suspen­
44 sion heated 52°C for 1 hour 64 128 5% 
45 prior to inoculation 64 128 Normal 
46 128 32 3% 
47 256 32 Normal 
Three weeks post-treatment for inoculated and vaccinated pigs. Con­
tact-exposed pigs had only been exposed to inoculated pigs for 3 days at 
the time of this bleeding. 
'^Estimated percentage of pneumonic lesions. 
^LAT titers are reciprocals of highest serum dilutions giving 
agglutination. 
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Table 3. LAT titers and percentage lung lesions in pigs inoculated simul­
taneously with heat inactivated M. hyopneumoniae by intravenous, 
footpad, and subcutaneous routes, and subsequently challenged 
with a M. hyopneumoniae lung suspension 
Pig 
No. 
Days post-inoculation Percentage lung lesion 
at necropsy" 0 7 19 25* 40 54 60 
13 <4 128f 512 1024 2048 2048 1024 0% 
14 <4 32 256 256 256 128 256 0% 
15 <4 8 1024 1024 2048 2048 2048 0% 
16 <4 <4 32 32 32 64 32 0.5% 
17 <4 256 1024 >4096 >4096 4096 4096 0% 
18 <4 128 512 1024 2048 2048 2048 0% 
"intranasal challenge of M. hyopneumoniae lung suspension given on 
this day. 
^Necropsy 60 days post-inoculation. 
^LAT titers are reciprocals of highest serum dilution giving agglu­
tination. 
challenge exposure. The LAT titers of the inoculated control group were 
much lower than the vaccinated group, ranging from less than 1:4 to 1:128 
Seven of eight inoculated pigs (Nos. 19, 21-26) had LAT titers at necrop­
sy, while five pigs (Nos. 19, 22, 23, 24, 26) had gross lesions at 
necropsy (Table 4). 
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Table 4. LAT titers and percentage lung lesions in nonvaccinated control 
pigs challenged with M. hyopneumoniae lung suspension 
Pig Days post-challenge Estimated percentage 
No. 0® 15 29 35 of lung lesions 
19 <4 32^ 64 128 25% 
20 <4 <4 <4 <4 0% 
21 <4 <4 8 4 0% 
22 <4 32 32 32 3% 
23 <4 8 32 64 0.5% 
24 <4 16 64 32 3% 
25 <4 8 16 16 0% 
26 <4 <4 8 8 0.5% 
^Corresponds to 25 days post-inoculation in Table 3. 
^LAT titers are reciprocals of highest serum dilution giving agglu­
tination. 
Duration of Latex Agglutination, Complement Fixation, and Indirect 
Hemagglutination Titers of M. hyopneumoniae Inoculated Swine 
As shown in Figure 3, LAT and IHA titers were found in the serum from 
one pig (No. 51) 2 weeks post-challenge, while the first evidence of a CF 
titer occurred 3 weeks post-inoculation. At 48 weeks post-inoculation, 
both IHA and LAT titers were still present, while the CF test had demon­
strated no detectable titer since 28 weeks post-inoculation. In the 
second pig (No. 52), all three tests detected an antibody response 3 to 4 
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necropsy at 18 weeks post-inoculation (Figure 4). In the remaining pig 
(No. 53) the CF test failed to detect an antibody response after 22 weeks 
post-inoculation while titers were found by both the LAT and IHA tests at 
48 weeks post-inoculation (Figure 5). 
Effect of Diethylaminoethyl (DEAE) Cellulose 
Treatment of Sera on LAT Titers 
As shown in Table 5, diethylaminoethyl cellulose treatment of sera 
from two pigs (Nos. 51, 53) experimentally inoculated with broth cultures 
of M. hyopneumoniae resulted in up to fivefold reductions in LAT titers. 
Untreated sera from one pig (No. 51) had LAT titers up to 1:320, but 
after DEAE cellulose treatment none of the sera had titers above 1:20. A 
similar pattern was observed in the LAT titers in post-inoculation sera 
from the second pig (No. 53). 
Effect of 2-Mercaptoethanol Treatment of Sera on LAT Titers 
The effects of 2-mercaptoethanol treatment of post-infection sera 
from three pigs (Nos. 51, 52, 53) inoculated with a M. hyopneumoniae broth 
culture are given in Table 6. Untreated sera from all three pigs attained 
maximum 1:320 LAT titers while no sera treated with 2-mercaptoethanol had 
greater than a 1:20 LAT titer. 
Repeatability of LAT Test Results 
Of the five pigs that exhibited normal appearing lungs at necropsy, 
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Figure 4. Duration of LAT, CF, and IHA post-inoculation titers 
®Lam, 1970. 
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Figure C. Duration of LAT, CF, and IHA post-inoculation titers 
*Lam, 1970. 
Table 5. Effect of diethyl aminoethyl (DEAE) cellulose treatment of sera on LAT titers 
Weeks post M. hyopneumoniae inoculation 
0 2 3 4 6 10 12 14 15 18 36 
Pig No, 51 Untreated 
sera 




<10 <10 <10 <10 <10 10 20 10 10 10 10 
Pig No. 53 Untreated 
sera 




<10 <10 <10 <10 <10 10 40 10 10 10 20 
^LAT titers are reciprocals of highest serum dilution giving agglutination. 
Table 6. Effect of 2-mercaptoethanol treatment of sera on LAT titers 
Weeks post M. hyopneumoniae inoculation 
0 2 3 4 6 10 12 14 15 18 36 
Pig No. 51 Untreated 
sera 




<10 <10 <10 <10 <10 10 10 10 20 10 10 
Pig No. 52 Untreated 
sera 




<10 <10 <10 <10 <10 <10 10 20 20 20 
Pig No. 53 Untreated 
sera 




<10 <10 <10 <10 <10 10 20 <10 <10 10 10 
^LAT titers are reciprocals of highest serum dilution giving agglutination. 
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the four successive tests using a different aliquot of the same sera for 
each titration. Two of the pigs (Nos. 232 and 287) were negative on week 
1, plus-minus on week 2, positive on week 3 at LAT titers of 1:8, and 
negative on week 4. Sera from the ten pigs challenged with M. hyopneu-
moniae were all LAT positive on the first test (Table 7). On the second 
and third test, all ten sera were still LAT positive. The fourth repeat 
test of the ten samples resulted in seven of ten samples still LAT posi­
tive, two samples plus-minus, and one sample negative. 
Specificity of Latex Agglutination Test 
for ^ hyopneumoniae Antibodies 
Experiment 1 
All pre-inoculation and post-inoculation sera from the five pigs 
. inoculated with M. hyosynoviae and the four pigs inoculated with M. hyo-
rhinis were negative in the ^ hyopneumoniae LAT. 
Experiment 2^ 
None of the sera from three pigs infected with lungworms (Meta-
strongylus spp. ) were found to have M. hyopneumoniae LAT titers. 
Experiment 3 
No titers were observed in the M. hyopneumoniae LAT with any of the 
post-infection sera from the two pigs experimentally infected with Ascaris 
suum. 
Experiment 4 
No detectable M. hyopneumoniae LAT titers were found in any of the 
sera from 20 pigs vaccinated with any of four commonly used swine vac­
cines. 
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Table 7. Repeatability of LAT test results 
Pig No. 
LAT titer of sample® on week 
1 2 3 4 
231 <8 <8 <8 <8 
232 <8 ±8 8 <8 
287 <8 ±8 8 <8 
289 <8 <8 <8 <8 
503 <8 <8 <8 <8 
36 le"^ 32 32 8 
37 32 32 64 16 
38 8 16 32 ±8 
39 128 256 256 64 
40 128 256 512 128 
41 128 128 256 64 
1 32 32 32 8 
2 16 32 32 ±16 
3 8 16 32 <8 
4 128 256 256 64 
Sera were divided into four aliquots and stored at -70°C. One set 
of aliquots was titered in LAT test on week 1, and a second set titered 
on week 2. Same procedure followed for weeks 3 and 4. 
^LAT titers are reciprocals of highest serum dilution giving agglu­
tination. 
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Attempts to Remove Nonspecific Agglutinins 
from Test Sera 
As shown in Table 8, swine RBC absorption of the ten serum samples 
from pigs (Nos. 492-501) with lungs showing no gross or microscopic le­
sions but which were LAT positive reduced LAT titers in all but the sera 
from pig (No. 495). Absorption of the same ten sera with sheep RBC re­
sulted in LAT titer reduction in sera from six pigs (Nos. 492-495, 498 
and 499). Sera from three pigs (Nos. 508, 509, and 510) inoculated with 
M. hyopneumoniae showed no change in LAT titers after absorption with 
either sheep or swine RBC. Sera from one pig (No. 507) showed a reduction 
in titer after absorption with either sheep or swine RBC, while sera from 
one pig (No. 511) showed only a titer reduction after absorption with 
swine RBC. Sera from four pigs (Nos. 502-506) that had normal lungs and 
were LAT negative remained LAT negative after absorption with either sheep 
or swine RBC. 
Effects on LAT Serum Titers of Various Physical and 
Chemical Treatments of M. hyopneumoniae Antigen 
Several chemical and physical treatments of M. hyopneumoniae resulted 
in a complete loss of detectable LAT antigen activity as measured against 
a known positive serum from a M. hyopneumoniae inoculated pig (No. 3). 
The fractions without LAT activity included the following: 1) residues 
after ether or chloroform extractions; 2) methanol soluble fractions; 3) 
supernatants after sonication, heat treatments of 45°C, 52°C, 65°C, or 
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Table 8. Effect on LAT titers^ of absorption of test sera with sheep or 
swine RBC 


























Pigs whose lungs 
showed no gross 
or microscopic 
lesions but were 
LAT positive 
Pigs whose lungs 
appeared normal and 
were LAT negative 
Pigs challenged 
with M. hyopneumoniae 
and whose lungs had 
gross and microscopic 
changes typical of 
MPS 
10 5 5 
80 40 10 
20 10 10 
10 10 5 
20 10 20 
10 5 10 
20 10 10 
80 10 20 
160 40 160 
160 40 160 
<5 <5 <5 
<5 <5 <5 
<5 <5 <5 
<5 <5 <5 
<5 <5 <5 
160 80 40 
80 80 80 
20 20 go 
40 40 40 
80 40 80 
^LAT titers are reciprocals of highest serum dilution giving 
agglutination. 
/ •  
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100°C, or combinations of both sonication and heat treatment; and 4) 
trypsin treated M. hyopneumoniae. 
As shown in Table 9, certain chemical and physical treatments of M. 
hyopneumoniae resulted in antigens possessing LAT activity. Both ether 
and chloroform soluble extracts of M. hyopneumoniae were active as LAT 
antigens at a 1:10 dilution. Of these two extracts, the ether extract 
reacted with higher serum dilutions of the five positive control sera, but 
did give a plus-minus reaction in one of the five negative control sera. 
A methanol insoluble fraction of M. hyopneumoniae was found to have LAT 
antigen activity at a dilution of 1:160 and gave the highest LAT positive 
control serum titers of any of the fractions. The methanol insoluble 
fraction also gave a plus-minus reaction in the same negative control 
serum as did the ether extract. The combination of sonication, then 
heating M. hyopneumoniae at 52°C for 30 minutes, resulted in a LAT antigen 
active at 1:160 dilution and gave positive control serum titers up to 
1:320. Genetron 113 treated M. hyopneumoniae was active at 1:80 dilutions 
and gave low LAT serum titers in positive control sera. 
Field Evaluation of hyopneumoniae LAT 
The CF titers, LAT titers, gross and microscopic lung evaluations, 
and lung isolation of M. hyopneumoniae from ten Iowa SPF herds are shown 
in Table 10. The majority of the pigs from herds 1 and 2 were found to 
have LAT and CF titers and possess lungs with both gross and microscopic 
lesions typical of MPS. M. hyopneumoniae were not isolated from the lungs 
of any pig in these two herds. Herds 3 and 6 were essentially negative 
Table 9. Effect on LAT titers® of various M. hyopneumoniae treatments 
Pig number 
LAT -
antigen Negative controls Positive controls 
M. hyopneumoniae treatment titer 502 503 504 505 506 4 5 51 19 52 
No treatment 80 <10 <10 <10 <10 <10 ±10 <10 <10 <10 ±20 
Sonicated 160 <10 <10 <10 <10 <10 40 20 40 40 160 
Heated at 52°C for 30 minutes 160 <10 <10 <10 <10 <10 40 20 80 40 160 
Heated at 52°C for 30 minutes, 
then sonicated 160 <10 10 ±10 10 ±20 80 80 160 80 160 
Sonicated, then heated for 30 
minutes at 52®C 160 <10 <10 <10 <10 <10 160 80 320 160 320 
Genetron 113 80 <10 <10 <10 <10 <10 10 10 20 10 20 
Ether extracted, ether soluble 
fraction 10 <10 <10 ±10 <10 <10 160 80 320 80 160 
Methanol extracted, methanol 
insoluble fraction 160 <10 <10 ±10 <10 <10 160 160 320 160 160 
Chloroform extracted, chloro­
form soluble fraction 10 <10 <10 <10 <10 <10 80 40 80 40 80 
Boiled, reconstituted 
centrifugate 160 <10 <10 <10 <10 <10 20 10 40 40 40 
Heated at 65°C for 30 minutes, 
reconstituted centrifugate 160 <10 <10 <10 <10 <10 20 20 40 40 40 
Heated at 45°C for 30 minutes, 
reconstituted centrifugate 160 <10 <10 <10 <10 <10 40 10 80 40 80 
®LAT titers are reciprocals of highest serum dilution giving agglutination. 
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Table 10. Field evaluation of M. hyopneumoniae LAT in ten Iowa SPF herds 
Gross Microscopic Lung iso-
Herd Pig CP LAT evidence evidence of lation of 
No. No. titer titer of MPS MPS hyopneumoniae 
551 4® 16^ + + -
552 16 128 - + -
553 4 ±8 + + -
554 16 64 - + -
555 ±4 8 + + contaminated 
556 4 64 - + -
557 <4 32 + + -
558 16 16 - ± -
559 4 16 - + -
560 16 16 + + -
561 <4 <8 - - -
562 <4 <8 - - -
563 <4 <8 - + -
564 <4 <8 - - -
565 <4 <8 - - -
566 ±8 16 + + -
567 <4 <8 - + contaminated 
568 16 ±16 + + -
569 8 <8 + ± -
570 4 16 - + -
571 <4 <8 + + -
572 ±4 64 - + -
^Complement-fixation titers are the reciprocals of the highest serum 
dilutions in which 70% or more of RBC were intact. 
h LAT titers are the reciprocals of the highest serum dilution showing 
agglutination. 
^BP indicates baby pigs 3 to 9 weeks of age. 
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Table 10. (Continued) 
Gross Microscopic Lung iso-
Herd Pig CF LAT evidence evidence of lation of ^ 
No. No. titer titer of MPS MPS hyopneumoniae 
573 8 32 + -
574 16 64 + ± -
575 <4 <8 + -
576 <4 <8 + -
577 <4 <8 + + 
578 <4 <8 + + 
579 <4 <8 + -
580 <4 <8 - -
581 <4 <8 ± -
582 <4 <8 + -
583 <4 ±8 + -
584 <4 ±8 + -
585 <4 8 + -
586 <4 <8 + -
587 <4 <8 - -
588 <4 <8 + -
589 <4 16 + -
590 <4 <8 ± -
591 <4 <8 - -
592 <4 <8 ± -
593 <4 <8 ± -
594 <4 <8 - -
595 <4 <8 - -
596 <4 <8 - -
597 <4 <8 - -
599 <4 <8 - -
600 <4 <8 - -
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Table 10. (Continued) 
Gross Microscopic 
Herd Pig CF LAT evidence evidence of 
No. No. titer titer of MPS MPS 
Lung iso­
lation of M. 
hyopneumoniae 
601 <4 <8 -
602 <4 <8 - -
603 <4 128 - -
604 <4 <8 - -
605 <4 128 - -
606 <4 <8 - + 
607 <4 <8 - -
608 <4 <8 - -
609 <4 <8 - + 
610 <4 <8 - -
611 >128 32 - ± 
612 >128 128 - -
613 >128 16 - ± 
614 >128 128 - -
615 >128 128 + ± 
616 >128 16 - + 
617 NT^ NT - -
618 32 16 - -
619 >128 128 - -
620 >128 64 - -
621 <4 128 - -
622 <4 32 + 
623 <4 <8 - -
624 <4 64 - -
^Serum not available. 
^Bacterial pneumonia. 
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Table 10. (Continued) 
Gross Microscopic Lung iso-
Herd Pig CF LAT evidence evidence of lation of ^ 
No. No. titer titer of MPS MPS h.yopneumoniae 
625 <4 16 - -
626 <4 <8 - + 
627 <4 <8 - + 
628 <4 <8 - -
629 <4 <8 - -
630 <4 <8 - ± 
631 <4 <8 - + 
632 ±8 <8 - + -
633 ±16 <8 - + -
634 <4 <8 - + -
635 <4 <8 - ± -
636 <4 <8 + + -
637 <4 <8 - - -
638 <4 8 + -
639 <4 <8 + ± -
640 <4 32 + + + 
641 <4 128 - + -
642 <4 <8 - + -
643 16 8 - ± -
644 <4 16 - + -
645 ±16 8 - + -
646 <4 <8 + + -
647 <4 <8 - + -
648 16 64 - + -
649 <4 8 - ± -
650 ±16 16 - + -
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lation of M. 
hyopneumoniae 
651 <4 <8 + -
652 <4 <8 + -
653 <4 <8 + -
654 <4 <8 + -
655 <4 <8 + -
656 <4 32 - -
657 <4 <8 - suspicious 
658 <4 <8 - suspicious 
659 <4 <8 ± -
660 <4 <8 - -
661 <4 8 - -
662 <4 ±8 - -
663 <4 <8 - -
664 <4 16 ± -
665 <4 16 ± -
667 <4 <8 + -
668 <4 <8 + -
669 <4 <8 + -
670 <4 <8 ± -
671 <4 <8 + ± -
672 <4 ±16 - -
673 <4 ±16 - -
674 <4 <8 ± -
675 <4 <8 - -
676 <4 ±16 - -
677 <4 32 ± -
678 <4 ±16 - -
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Table 10. (Continued) 
Gross Microscopic Lung iso-
Herd Pig CF LAT evidence evidence of lation of ^ 
No. No. titer titer of MPS MPS hyopneumoniae 
679 <4 <8 - + + 
680 <4 <8 - + + 
681 <4 <8 - + + 
682 <4 <8 - + + 
683 <4 <8 + + -
684 <4 <8 - + -
685 <4 16 - + -
686 ±8 32 - - -
687 ±8 32 - + -
688 <4 32 - ± -
689 <4 64 - + -
690 <4 16 - + -
691 <4 128 - + -
692 <4 <8 - + -
693 <4 <8 - + -
694 <4 16 + + -
695 <4 8 + + + 
696 <4 ±16 - + -
697 <4 32 + - -
698 <4 <8 + + -
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for MPS both serologically and culturally, and had no evidence of gross 
pneumonic lesions. Histopathologically, however, both herds showed evi­
dence of MPS. Herds 4 and 8 were basically negative for MPS by all five 
parameters. Herds 5 and 7 were found positive for MPS as judged by 
serological results and microscopic lung evaluations, but were negative 
for MPS based on gross lung evaluation and cultural isolation. Pigs from 
herd 9 were considered negative for MPS by all parameters except the LAT. 
Herd 10 contained pigs that had microscopic lung lesions and positive LAT 
results, but were negative for MPS in the CF test. M. hyopneumoniae was 
not isolated from the lungs of these pigs and no gross lung lesions were 
obtained. As shown in Tables 11a and b, correlation of LAT and CF results 
with gross pneumonic lesions of the 95 adult pigs in this study showed 
that of the 12 pigs with gross pneumonic lesions, eight were positive in 
both the LAT and CF tests. Of the 83 pigs with normal lungs, 37 were LAT 
negative and 60 were CF test negative. A summary of microscopic lung 
evaluations, CF and LAT titers of the 95 adult pigs in this study are 
shown in Table 12a and b. Of 63 pigs with microscopic lesions typical of 
MPS, 40 had LAT titers and 26 had CF titers. LAT titers were found in 15 
pigs with normal lungs while six pigs with normal lungs were CF positive. 
Of the 32 pigs with normal lungs, 17 were both CF and LAT negative. 
Of ten groups of baby pigs from the ten Iowa SPF herds, herds 5BP, 
6BP, and lOBP were LAT positive (Table 10). In both 5BP and lOBP, four of 
five pigs were LAT positive, while two of five pigs from herd 6BP were LAT 
positive. In herd 5BP, four of five pigs had normal lungs while the re­
maining pig had a lung with a gross lesion that was considered caused by a 


























No. of pigs 8 1 25 35 2 2 1 21 
Table lib. Summary of LAT and CF test results and gross pneumonic lesions in 
SPF herds 

















No. of pigs 9 46 3 37 9 23 3 60 
Table 12a. Summary of LAT, CF test results, and lung histopathology of pigs from ten Iowa 
SPF herds 
+LAT +LAT +LAT -LAT -LAT -LAT -LAT +LAT 
+CF -CF -CF -CF +CF -CF +CF +CF 
+Lesions +Lesions -Lesions -Lesions -Lesions +Lesions +Lesions -Lesions 
No. of pigs 23 17 9 17 0 20 3 6 
Table 12b. Summary of LAT, CF test resul'ts, and lung histopathology of pigs from ten Iowa 
SPF herds 
+LAT +LAT -LAT -LAT +CF +CF -CF -CF 
+Lesions -Lesions +Lesions -Lesions +Lesions -Lesions +Lesions -Lesions 
No. of pigs 40 15 23 17 26 6 37 26 
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bacterial infection upon microscopic examination. Herds lOBP and 6BP had 
lung lesions that were both microscopically and grossly typical of MPS. 
Herd 6BP also had a Bordetella bronchiseptica pneumonia. Baby pigs from 
herds 2BP, 3BP, 4BP, 7BP, 8BP, and 9BP had grossly normal lungs, but 
showed evidence of MPS microscopically. Isolation of M. hyopneumoniae was 
made from lungs of baby pigs from herds 2BP, 6BP, 9BP, and lOBP. 
Of the 50 sera and lungs collected from pigs that entered Veterinary 
Diagnostic Laboratory at Iowa State University during a 3 month period, 
sera from 17 of 21 pigs whose lungs had typical gross lesions of MPS were 
found positive in both the LAT and CF test (Table 13). Sera from 21 of 29 
pigs who had normal lungs were negative in both the CF and LAT tests. 
The 27 sera from three Nebraska SPF herds show general agreement of 
LAT, CF test, and lung lesion results in herds 13 and 14 (Table 14). In 
herd 13, serological and lung data indicated M. hyopneumoniae infection, 
while in herd 14, serological, lung, and cultural data indicated the 
herd free of MPS. In herd 15, lungs from all 15 pigs had typical gross 
MPS lesions and M. hyopneumoniae was isolated from the lungs of all 15 
pigs. Of the corresponding sera, 14 of 15 were LAT positive or plus-minus 
while 13 of 15 sera were CF negative. 
The correlation of LAT and CF test results of 106 swine sera from 
five additional Iowa SPF herds with microscopic lung data of penmate pigs 
is shown in Table 15. All 20 pigs in herd 3 tested CF and LAT positive 
for M. hyopneumoniae antibodies, while seven of ten penmates had micro­
scopic lung changes characteristic of MPS. In herds 1 and 2, all penmates 
had normal lungs but four of 20 pigs from herd 1 and three of 21 pigs from 
Table 13. Correlation of LAT and CF test results and gross pneumonic lesions in 50 pigs from 
Veterinary Diagnostic Laboratory 
+LAT +LAT +LAT -LAT -LAT -LAT -LAT +LAT 
+CF -CF -CF -CF 4CF -CF +CF +CF 
+Lesions +Lesions -Lesions -Lesions -Lesions +Lesions +Lesions -Lesions 
No. of pigs 17 4 8 21 0 0 0 0 
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Table 14. Field evaluation of M. hyopneumoniae LAT in three Nebraska 
swine herds 
Pig Gross Microscopic 
Herd No. CF LAT lesion lesion Culture 
749 16® 16 + - N.D.b 
750 ±32 32 + + N.D. 
751 32 64 + + N.D. 
752 32 32 + + N.D. 
753 ±8 32 + + N.D. 
754 32 64 + + N.D. 
755 <4 <8 - N.D. -
756 <4 8 - N.D. -
757 <4 <8 - N.D. -
758 <4 <8 - N.D. -
759 ±8 <8 - N.D. -
760 <4 <8 - N.D. -
761 <4 64 + N.D. + 
762 ±8 64 + N.D. + 
763 ±16 32 + N.D. + 
764 <4 ±8 + N.D. + 
765 <4 64 + N.D. + 
766 <4 <8 + N.D. + 




Table 14. (Continued) 
P i g  Gross Microscopic 
Herd No. CF LAT lesion lesion Culture 
767 <4 64 + N. D. + 
768 <4 64 + N. D. + 
769 <4 32 + N.D. + 
770 <4 16 + N.D. + 
771 <4 16 + N.D. + 
772 <4 64 + N.D. + 
773 <4 ±8 + N.D. + 
774 <4 8 + N.D. + 
775 <4 64 + N.D. + 
Table 15. Correlation of CF and LAT test results with lung histopathology 
of penmates of 106 pigs from five additional Iowa SPF herds 
Herd +LAT +LAT -LAT -LAT Microscopic evaluation 
No. +CF -CF -CF +CF of lungs of penmates 
1 0 4 16 0 10/10 normal 
2 0 3 17 1 10/10 normal 
3 20 0 0 0 7/10 typical MPS 
4 3 6 10 2 10/10 normal 
5 12 6 4 2 7/26 typical MPS 
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herd 2 had LAT titers. Only one pig from these two herds had a positive 
CF test. In herd 4, ten of 21 pigs were CF and LAT negative, but ten of 
ten penmates had normal lungs. Twelve of 24 pigs from herd 5 were posi­
tive in both the CF test and LAT while seven of 26 penmates had micro­
scopic lung lesions characteristic of MPS. 
LAT and CF test results and microscopic lung data of 107 pigs from 
swine herds located in Iowa, California, and Texas are shown in Tables 
16a and b. Of the 61 pigs whose lungs were found histopathologically 
posit ive for MPS, corresponding sera gave the fol lowing results: 1) 32 
LAT and CF positive; 2) 14 LAT positive and CF negative; 3) 12 LAT and CF 
negative; and 4) three LAT negative and CF positive. Of the 46 pigs whose 
lungs were normal, the corresponding sera gave the following results: 1) 
ten LAT positive and CF negative; 2) 22 LAT and CF negative; 3) six LAT 
negative and CF positive; and 4) eight CF and LAT positive. 
Of 36 sera from 8 months old pigs that had been CF negative on three 
successive tests, 33 of 36 sera were found LAT negative. 
Sera from 28 3 months old CF negative pigs were all negative in the 
LAT. 
Latex agglutination titers of 20 sows and three 6 to 8 weeks old baby 
pigs farrowed by the sows are shown in Table 17. All six LAT negative 
sows had three LAT negative baby pigs. Of the 14 LAT positive sows, four 
sows had three LAT negative baby pigs, one sow had two negative and one 
positive LAT baby pigs, four sows had two positive and one negative LAT 
baby pigs, and five sows had three LAT positive baby pigs. Lungs from all 
six LAT negative sows were normal, while nine of 14 LAT positive sows had 
lungs with gross MPS pneumonic lesions. 
Table 16a. Summary of LAT, CF test results, and lung histopathology of 107 pigs from Iowa, Texas, 
and California herds 
+LAT +LAT +LAT -LAT -LAT -LAT -LAT +LAT 
+CF 
-CF -CF -CF +CF -CF +CF +CF 
+Lesions +Lesions -Lesions -Lesions -Lesions +Lesions +Lesions -Lesions 
No. of pigs 32 14 10 22 6 12 3 8 
Table 16b. Summary of LAT, CF test results, and lung histopathology of 107 pigs from Iowa, Texas, 
and California herds 
+LAT +LAT -LAT -LAT +CF +CF -CF -CF 
+Lesions -Lesions +Lesions -Lesions +Lesions -Lesions +Lesions -Lesions 

























Correlation of LAT results and gross MPS pneumonic lesions of 
20 sows with the LAT results of 6 to 8 weeks old baby pigs 
farrowed by the sows 
LAT titers LAT results of Estimated percentage 
of sows baby pigs of lung lesions 
<8 3 negatives 0 
<8 3 negatives 0 
64 2 positives 1 negative 20 
128 3 positives 15 
128 3 positives 0 
<8 3 negatives 0 
128 2 positives 1 negative 0 
64 3 positives 20 
128 3 negatives 0 
<8 3 negatives 0 
128 3 negatives 10 
64 3 negatives 0 
64 3 negatives 10 
256 3 positives 10 
128 2 positives, 1 negative 3 
128 1 positive. 2 negatives 15 
<8 3 negatives 0 
<8 3 negatives 0 
16 2 positives, 1 negative 15 
128 3 positives 0 
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DISCUSSION 
It was found that latex agglutination antibodies were first detected 
in three pigs inoculated with M. hyopneumoniae 2 to 3 weeks post-inocula­
tion and persisted until necropsy at 24 weeks, at which time the lungs 
from all three pigs were grossly normal. The lack of gross pneumonic 
lesions probably indicated recovery of the pigs from MPS during the ex­
periment. Livingston et al. (1972) reported that gross pneumonic lesions 
of swine due to uncomplicated M. hyopneumoniae infection often resolved by 
6 weeks post-infection. Thus, it is probable that the three pigs had 
recovered by 24 weeks. Additional evidence indicating that the pigs had 
recovered from MPS was provided by CF test results. Previous work by 
Slavik and Switzer (1972) suggested that CF titers often paralleled the 
development and resolution of pneumonic lesions in uncomplicated cases of 
M. hyopneumoniae swine pneumonia. That is, as pigs developed gross 
pneumonic lesions, CF titers first appeared, while during resolution of 
the lesions, CF titers fell. In this particular group of three pigs, CF 
antibodies were first detected 3 to 4 weeks post-inoculation and lasted up 
to 15 weeks post-inoculation. This was 9 weeks before necropsy and was 
sufficient time for resolution of MPS pneumonic lesions. 
When a shorter time period elapsed between intratracheal inoculation 
of pigs with M. hyopneumoniae and necropsy, good correlation existed be­
tween LAT results and MPS pneumonic lesions. This correlation between LAT 
titers and gross and microscopic lesions was demonstrated in a group of 
six pigs that received intratracheal inoculations of ^ hyopneumoniae. 
Five of six pigs developed LAT titers at 2 weeks post-inoculation, while 
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the remaining pig developed a LAT titer at 3 weeks post-inoculation. At 
necropsy, 4 weeks post-inoculation, all six pigs were still LAT positive. 
Examination of their lungs revealed four of six lungs had both gross and 
microscopic lesions typical of MPS. One of two pigs with grossly normal 
lung had microscopic changes indicative of MPS. 
Latex agglutination titers in three contact exposed pigs were de­
tected 4 to 12 weeks post-contact. At necropsy 24 weeks post-contact, LAT 
titers were still present in all three pigs. CF titers in these three 
pigs were detected 8 to 15 weeks post-contact and only one pig had a CF 
titer at necropsy. Lung examination revealed one of three pigs had gross 
pneumonic lesions, the pig with a CF titer at necropsy. 
In a direct comparison of duration of CF, LAT, and IHA titers, the 
relative long duration of LAT and IHA titers in relationship to persist­
ence of CF titers was demonstrated. In two M. hyopneumoniae inoculated 
pigs, both the IHA and LAT detected antibodies 1 week earlier than the CF 
test. During the course of the experiment, LAT titers were generally one 
to two twofold dilutions higher than CF titers and two to three twofold 
dilutions lower than IHA titers. In both pigs, LAT and IHA titers were 
present at 48 weeks post-inoculation, while CF titers fell below detecta­
ble levels at 28 weeks post-inoculation in one pig and 22 weeks post-
inoculation in the second pig. The effect of the relative long persist­
ence of LAT titers on the use of the LAT test as a diagnostic test will be 
discussed later. 
Correlation of latex agglutination titers and protection in swine 
against M. hyopneumoniae infection was demonstrated in this study. In one 
experiment, a group of six pigs that had received no treatments and a 
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group of six pigs that had received intratracheal inoculations of a heat-
inactivated 1:40 M. hyopneumoniae suspension 3 weeks earlier and had de­
veloped demonstrable LAT titers were put into contact with six pigs that 
previously had been intratracheally inoculated with a M. hyopneumoniae 
pneumonic lung suspension. Five of six untreated pigs were found to have 
pneumonic lesions typical of MPS after 34 or more days exposure to the M. 
hyopneumoniae lung suspension inoculated pigs. Of the six pigs that had 
received intratracheal inoculations of heat-inactivated M. hyopneumoniae, 
four of six had normal lungs. Thus, the presence of LAT titers in the 
pigs indicated the pigs possessed partial protection against subsequent 
M. hyopneumoniae infection. 
An interesting sidelight to the above experiment was observed. Al­
though the six pigs inoculated with a M. hyopneumoniae lung suspension and 
the six pigs inoculated with heat-inactivated M. hyopneumoniae received 
the respective treatments on the same day via the same route, on day 18 
post-treatment the LAT titers of the six pigs receiving the heat-inacti­
vated organisms ranged from 1:32 to 1:256 while the group receiving the 
lung suspension had LAT titers of 1:8 to 1:32. Although the most probable 
explanation for differences in LAT titers of the two groups would be the 
relative concentration of M. hyopneumoniae in each inoculum, another 
possibility exists. Heating might reveal antigenic determinants on the 
mycoplasmal membrane that are more highly antigenic, thus eliciting a 
stronger antibody response than normally occurs. 
In a second experiment, correlation of latex agglutination titers in 
pigs and protection against subsequent M. hyopneumoniae was even more con­
clusively demonstrated. Of six pigs that received simultaneous inocula-
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tions of heat-inactivated M. hyopneumoniae by intravenous, footpad, and 
subcutaneous routes 25 days before they were intranasally challenged with 
a M. hyopneumoniae pneumonic lung suspension, five pigs had normal lungs 
35 days after challenge. The remaining pig had a small lung lesion typi­
cal of MPS, In the nonvaccinated control group, five of eight pigs had 
gross pneumonic lesion typical of MPS 35 days after challenge with the M. 
hyopneumoniae lung suspension. In the vaccinated group of pigs, the one 
pig with a pneumonic lesion had the lowest LAT titer at necropsy, 1:32. 
Of the remaining five vaccinates, one pig had a LAT titer of 1:256 at 
necropsy while the other four pigs had LAT titers of 1:1024 or greater at 
this time. Thus, from these results it appears that stimulation of a 
pig's humoral antibody level against M. hyopneumoniae is correlated with 
protection against subsequent infection of the pig by M. hyopneumoniae. 
That humoral antibodies themselves play an important role in this protec­
tion was not determined in this study. Since the one vaccinated pig with 
the lowest LAT titer was the only pig with a pneumonic lesion after 
challenge, it would appear that humoral antibodies do have some role in 
protection. Studies by other workers including Lam and Switzer (1971b) 
have shown that humoral antibodies play a major role in preventing M. hyo­
pneumoniae infection in pigs. They found that passively transferring 
serum from pigs vaccinated against M. hyopneumoniae into other pigs pre­
vented subsequent infection of the recipient pigs by ^ hyopneumoniae. 
Studies by other workers including Holmgren (1974c) have indicated that 
secretory IgA plays a major role in protection of pigs against M. hyopneu­
moniae infection. In addition, recent work by Roberts (1973) demonstrated 
cell-mediated immunity using M. hyopneumoniae. Thus, only future research 
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will answer what type of humoral and cellular responses play the most 
significant role in protecting pigs from ^ hyopneumoniae infection. 
Both DEAE cellulose absorption and 2-mercaptoethanol treatment of 
sera from M. hyopneumoniae inoculated pigs indicate that M. hyopneumoniae 
LAT titers are due to 19S immunoglobulins. This is in agreement with GoiS 
et al. (1972) who found that LAT activity was in IgM fractions of serum 
from pigs infected with M. hyorhinis. 
No LAT titers were observed in the M. hyopneumoniae LAT test with 
sera from pigs infected with other swine mycoplasmas, including M. hyo­
rhinis and M. hyosynoviae. Serum from pigs infected with Metastrongylus 
spp. or Ascaris suum did not react in the M. hyopneumoniae LAT. In addi­
tion, pigs vaccinated with four commonly used swine vaccines did not 
develop antibodies that cross-reacted in the M. hyopneumoniae LAT. These 
initial results indicate that the use of the LAT test for diagnosis of M. 
hyopneumoniae in field studies should not be influenced by the above 
factors. Additional specificity studies, however, should be done before 
the LAT is used on a widespread basis for diagnosis of M. hyopneumoniae 
infections in pigs. 
One major problem faced throughout this study was the inability to 
completely standardize LAT reagents and conditions to obtain results that 
were always reproducible. As shown by the experiment involving the re­
peatability of LAT serum titers, some sera showed a variation in LAT 
titers when titered on four separate occasions. Since all the sera in 
this experiment were divided into four aliquots, one of which was titered 
on week 1, the second on week 2, and so on, and since all aliquots were 
frozen at -80°C until titered, factor or factors other than sera insta­
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bility were responsible for serum titer variation. Some workers, in­
cluding Kende (1969), have indicated that the use of freshly prepared 
glycine buffer was necessary to obtain the best results with the latex 
agglutination test. This seemed to be partly true in the present study. 
Glycine buffer made up the same day it was used often worked better in the 
LAT than did glycine buffer made up 2 or more weeks previously. In this 
study, however, the M. hyopneumoniae LAT antigen was more likely re­
sponsible for serum titer variation. Optimal M. hyopneumoniae LAT antigen 
dilutions ranged from 1:40 to 1:320, depending on the particular harvest. 
Oftentimes, the lower 1:40 optimal dilution antigen gave plus-minus re­
actions with the negative control serum. Even when a single harvest of 
antigen was aliquoted and frozen at -20°C, variation in antigen and serum 
LAT titers occurred with different aliquots. This variation in titers 
might have been due to how rapidly the antigen was frozen or thawed, 
storage time at -20°C, or how the antigen was handled after thawing. As a 
general rule, it was found in this study that the higher titer a particu­
lar M. hyopneumoniae harvest was as a CF antigen, the higher titer it was 
as a LAT antigen. 
Several procedures were used in this study to help compensate for 
lack of complete standardization of the test. These procedures included 
the following: (1) four negative and four positive controls were titered 
before titering any test sera to increase the probability of obtaining 
acceptable test serum results; (2) when replacing test reagents, only one 
reagent was replaced in any given test to facilitate solving any problem 
that might arise from a new reagent; and (3) all reagents were brought to 
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37°C before being used in the LAT test to eliminate any problem due to 
temperature variation of reagents. 
One additional technique should be noted. At times, centrifugation 
of test serum and M. hyopneumoniae antigen-latex complex resulted in less 
defined agglutination than normal. In these cases, a second centrifuga­
tion often gave a much stronger agglutination pattern. 
The use of washed, whole cell M. hyopneumoniae as the LAT antigen met 
with little success in this study since positive control swine sera often 
did not react in the LAT when this LAT antigen was used. Since previous 
workers, including Morton (1966), had found that sonication of a particu­
lar mycoplasma would increase its LAT antigen activity, a sonicated M. 
hyopneumoniae suspension was evaluated as a LAT antigen. It was found 
that M. hyopneumoniae sonicated for 30 seconds to a minute yielded a LAT 
antigen that reacted with 1:20 to 1:160 dilutions of various positive con­
trol sera. Increased LAT antigen activity of M. hyopneumoniae after soni­
cation probably was due to two reasons. First, sonication dispersed large 
aggregates of M. hyopneumoniae into smaller aggregates, thus increasing 
the number of cell membrane antigenic determinants to react with specific 
antibodies. Second, sonication might have altered surface configuration 
of the mycoplasmal membrane to reveal antigenic groups. Since previous 
work by Slavik and Switzer (1972) had indicated that heating M. hyopneu­
moniae at 52°C for 30 minutes was necessary to obtain a usable CF antigen, 
the effect of this heat treatment on M. hyopneumoniae's LAT antigen 
activity was determined. The result was a LAT antigen that reacted simi­
larly to the sonicated hyopneumoniae. Heating ^ hyopneumoniae prob­
ably increased the LAT antigen activity by removing medium components or 
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metabolic wastes attached to the membrane's surface, thus, possibly re­
vealing membrane antigenic determinants. Combinations of the heat treat­
ment first, then sonication, or sonication first then heat treatment were 
evaluated next. It was then found that M. hyopneumoniae sonicated for 30 
seconds, then heated at 52°C for 30 minutes resulted in a M. hyopneumoniae 
LAT antigen that reacted at dilutions of up to 1:320 with positive control 
sera, but did not react with negative control sera. If M. hyopneumoniae 
were heated first, then sonicated, the result was a LAT antigen that re­
acted with positive control sera at dilutions of up to 1:320, but also 
reacted with several negative control sera. The reaction of this antigen 
with negative control sera was probably due to the sonication altering the 
antigenic determinants exposed on the mycoplasmal membrane by the heat 
treatment. These altered antigenic determinants then could react non-
specifically with components in the negative control sera. 
M. hyopneumoniae was subjected to additional chemical and physical 
treatments to determine more about the LAT antigenic determinants and, 
more importantly, to obtain a more specific LAT antigen. As will be dis­
cussed later, it was found in the latter stages of this study that the 
correlation of LAT titers in field cases with other parameters indicating 
M. hyopneumoniae infection of swine was often poor. One possible explana­
tion for the poor correlation was that the LAT was not totally specific 
for M. hyopneumoniae. To evaluate the specificity of the M. hyopneu­
moniae LAT, three avenues were explored. As previously discussed sera 
from pigs infected with other swine mycoplasmas, lungworms. Ascaris suum, 
or pigs vaccinated with commonly used swine vaccines were titered in the 
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M. hyopneumom'ae LAT. No cross reactions were observed in any of these 
sera using the 1^ h.yopneumoniae LAT antigen. 
Absorption of test sera was a second method used to determine if 
specificity of the LAT could be improved. Sera from pigs that had LAT 
titers but had gross and microscopic normal lungs were absorbed with either 
sheep or swine RBC and retitered in the LAT. It was hoped that if non­
specific LAT reaction were due to naturally occurring Forssman antibodies 
in swine sera, absorption with sheep RBC would remove these Forssman anti­
bodies. Absorption of swine sera with swine RBC was hoped to remove any 
serum components that might also react with the M. hyopneumoniae LAT 
antigen. It was found that the majority of positive LAT sera from pigs 
with normal lungs did have reduced LAT titers after absorption with swine 
RBC, and about 50% of the sera had reduced LAT titers after absorption 
with sheep RBC. From these results it would appear that additional 
methods to remove nonspecific agglutinins from sera should be evaluated. 
Chemical and physical methods were evaluated for their ability to 
modify the LAT antigen so that it was specific for M. hyopneumoniae. 
Preliminary results indicated that ether soluble fractions, chloroform 
soluble fractions, methanol insoluble fractions, or a boiled, reconstituted 
centrifugate of M. hyopneumoniae were the most promising LAT antigens 
evaluated. All these LAT antigens reacted with fairly high dilution of 
positive control sera, and usually did not react with negative control 
swine serum. Due to the difficulty in harvesting adequate volumes of M. 
hyopneumoniae to use for extraction, however, the specificity of these 
extracts was not evaluated. Any future work with the M. hyopneumoniae 
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LAT, however, should include evaluations of the specificity of these 
extracts and others. 
The effect on LAT activity of the various chemical and physical 
treatments of M. hyopneumoniae indicated a complex LAT antigen. The LAT 
antigen apparently contains a lipid moiety as suggested by its solubility 
in ether and chloroform. Polypeptide determinants are a possibility since 
some polypeptides could go into the ether and chloroform extracts and 
polypeptides would not be destroyed by boiling. A polysaccharide moiety 
is also suggested by the resistance of the LAT antigen to boiling. Per­
haps in future studies, isolation and identification of specific LAT 
antigenic determinants should be attempted. 
On an individual pig basis, the accuracy of the LAT was difficult to 
evaluate in this study. This was due to the lack of an absolute indicator 
of M. hyopneumoniae infection. Gross evaluation of lungs is probably an 
unreliable indicator of the disease because other pneumonia producing 
agents can cause lesions that mimic typical MPS lesions. In addition, 
some M. hyopneumoniae infected pigs may not develop gross pneumonic le­
sions. Diagnosis of MPS based on microscopic lung lesions is also often 
difficult. Many field cases of mycoplasmal pneumonia of swine are compli­
cated by secondary bacterial and mycoplasmal agents. Thus, microscopic 
lung changes typical of M. hyopneumoniae infection are often masked by 
lung changes produced by other secondary invaders. Another indicator of 
MPS, the complement fixation test, has not been totally evaluated. As of 
now, the CF test appears to have the most value in diagnosing MPS on a 
herd basis. 
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The one parameter that could answer many questions concerning the 
value of the LAT, CF test, and gross and microscopic lung lesions in the 
diagnosis of MPS in individual pigs is the cultural recovery of M. hyo-
pneumoniae from the lungs. Unfortunately, it is not as yet possible to 
isolate and identify M. hyopneumoniae with any high degree of success 
because of the lack of adequate isolation media. Only when such medium is 
developed and M. hyopneumoniae can be isolated and identified with a high 
degree of accuracy can the value of other MPS diagnostic methods be 
thoroughly evaluated. 
In the present study, attempts to correlate LAT results with gross 
and microscopic lung lesions, CF test results, and M. hyopneumoniae iso­
lation from lungs of 95 market weight pigs from ten Iowa SPF herds empha­
sized the difficulty in diagnosing MPS in individual pigs. For example, 
a one-way correlation was found between gross and microscopic results. 
Sixty-three of 95 pigs had microscopic lesions typical of MPS, while only 
12 of 95 pigs had gross lesions. All 12 pigs with gross MPS lesions, 
however, did have microscopic lesions typical of MPS. Of these 12 pigs 
with gross lung lesions, eight were positive in both the CF test and LAT. 
Two additional pigs with gross lung lesions were also serologically test 
positive, one each in the LAT and CF test. Thus, both tests detected 75% 
of the pigs with gross lesions. Of the 83 pigs with grossly normal lungs, 
however, 76% were CF negative, while only 45% were LAT negative. Chi 
square analysis of these data at a 0.05 significance level indicates that 
latex agglutination results and gross lung results are independent of each 
other, while CF results and gross lung results are dependent upon each 
other. The most probable explanation for these results is that CF titers 
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more closely parallel gross lesion formation and resolution than do LAT 
titers. Another possible explanation is that the LAT is less specific 
than the CF test. 
In this same group of 95 pigs, 63 pigs had lungs with microscopic 
lesions typical of MPS. Of these 63 pigs, 63% were LAT positive and 41% 
were CF positive. Of the 32 pigs with microscopically normal lungs, 81% 
were CF negative and 53% were LAT negative. Stated another way, of 32 CF 
positive pigs, 26 had microscopic lung lesions while of 55 LAT positive 
pigs, 40 had microscopic lung lesions. Chi square analysis of these data 
at 0.05 significance level indicates that latex agglutination results and 
microscopic lung results are independent of each other, while CF results 
and microscopic lung results are dependent on each other. That is, if a 
serum sample is positive in the CF test, there is an 81% chance that the 
pig will have microscopic lung lesions typical of MPS. A negative CF 
serum, however, gives little indication that the pig will not have lungs 
with microscopic lesions. In fact, in this particular field study, 58% 
of the pigs that were CF negative had microscopic lung lesions. Thus, 
the value of the CF test on an individual pig basis rests upon CF positive 
results which indicates the pig probably has gross and/or microscopic 
lesions. The failure of the LAT to predict presence or absence of micro­
scopic lung lesions at a 0.05 significance level may be due to several 
factors: 1) the LAT may be more sensitive in detecting M. hyopneumoniae 
antibodies in lesionless carriers than is the CF test; 2) LAT antibodies 
persist after microscopic lesion resolution longer than CF antibodies do; 
and 3) microscopic evaluation of the lung may not be an accurate parameter 
89 
of MPS infection. The possibility that the LAT is less specific than the 
CF test must also be considered. 
In a group of 107 pigs from Iowa, Texas, and California, both LAT and 
CF test results were found dependent on microscopic lung data as corre­
lated by chi square analysis at 0.05 significance level. Of the 61 pigs 
whose lungs had microscopic lesions of MPS, 75% were LAT positive and 57% 
were CF positive. Of the 46 pigs with microscopically normal lungs, 70% 
were CF negative and 61% were LAT negative. These data indicate that the 
LAT might be a better indicator of the presence of microscopic lesions 
than the CF test. 
In another field study, both the LAT and CF test results were found 
to predict gross lung lesions at a 0.01 significance level using chi 
square analysis. Of 50 pig lungs obtained from the Veterinary Diagnostic 
Laboratory, 21 lungs had gross lung lesions typical of MPS. All 21 sera 
from corresponding pigs were found positive in the LAT test while 81% of 
these sera were CF positive. The LAT, however, also indicated eight of 
29 sera from pigs with grossly normal lungs were positive, while all 29 
sera were CF negative. 
Field correlation of M. hyopneumoniae LAT in pigs from three Nebraska 
swine herds with culture results, CF test results, and gross and micro­
scopic lesion data was encouraging. In one herd, all six pigs tested were 
CF test positive or plus-minus and LAT positive. Lung evaluation revealed 
all six pigs had gross lesions typical of MPS while five of six had micro­
scopic lesions of MPS. In a second herd, all six pigs had grossly normal 
appearing lungs. Five of six pigs were CF negative and one pig was CF 
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plus-minus. Latex agglutination test results indicated five of six pigs 
were MPS negative, and one of the CF negative pigs was MPS positive. No 
M. h.yopneumoniae was isolated from lungs of any of the six pigs. In a 
third herd, four of six pigs were CF test negative and two pigs were CF 
test plus-minus, while five of six pigs were LAT positive. All six pigs 
were found to have lungs with gross lesions and mycoplasmal colonies re­
sembling M. hyopneumoniae were isolated from all six lungs. Thus, in this 
particular field study, good correlation of gross and microscopic lung 
lesions and CF test and LAT results enabled the MPS status of the herds 
to be defined. 
Chi square analysis at 0.05 significance level indicated a corre­
lation of CF and LAT results of 106 pigs from five additional Iowa 
SPF herds with the lung histopathology of penmates. In two of the herds 
in which penmates had normal microscopic lungs, over 80% of the pigs were 
CF and LAT negative. Seven of 41 pigs from these two herds were LAT 
positive, while only one of 41 pigs was CF positive. In a third herd in 
which penmates had normal lungs 16 of 21 pigs were CF negative and 12 of 
21 pigs were LAT negative. In the two herds in which penmates had pneu­
monic lesions, one herd had all 20 pigs both CF test and LAT positive. 
In the second herd, 75% of the pigs were LAT positive and 58% were CF 
positive. These results again indicate that diagnosis of MPS on a herd 
basis can be made with LAT and CF test results. 
Correlation of LAT results and gross MPS pneumonic lesions of 20 sows 
with LAT results of 6 to 8 weeks old baby pigs farrowed by the sows re­
vealed all six LAT negative sows farrowed LAT negative pigs. In addition, 
lungs from these six LAT negative sows, were normal. These results 
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suggest that a future application of the LAT might include attempts to 
farrow pigs free from MPS by utilizing LAT negative sows. 
Both experimental and field evaluations have indicated a limited role 
for the M. hyopneumoniae latex agglutination test at this time. Experi­
mental results indicated that LAT titers persist for up to 48 weeks. 
Thus, in most cases it would be difficult to ascertain from LAT results if 
an active M. hyopneumoniae infection were present in any given herd. Even 
though the use of paired serum samples might alleviate this problem some­
what, other factors favor the use of the microtitration CF test over the 
LAT in diagnosing naturally occurring MPS. Complement fixation test re­
sults are more repeatable than LAT, less M. hyopneumoniae antigen is used 
in the CF test, and the microtitration CF test is capable of testing a 
larger number of test sera per time period than the LAT. In addition, in 
the present study most field evaluations indicated that the results of the 
CF test correlated as well with the other MPS parameters as did the LAT. 
Considering these factors, it appears the use of the LAT has limited value 
in field diagnosis of MPS. 
In a research situation, however, the LAT has several possibilities. 
In immune response studies of pigs infected with M. hyopneumoniae, humoral 
antibody response could be monitored by the latex agglutination test. 
Thus, perhaps the role of humoral antibodies in the immune response of a 
pig to M. hyopneumoniae infection can be ascertained. In addition, future 
drug or vaccine trials could use the LAT to indicate humoral antibody 
response in pigs to M. hyopneumoniae challenge. 
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SUMMARY 
A tube latex agglutination test (LAT) for diagnosis of mycoplasmal 
swine pneumonia (MPS) was developed. Latex agglutination antibodies 
against M. hyopneumoniae in experimentally inoculated pigs were detected 
2 to 3 weeks post-inoculation. This was usually a week or more earlier 
than a microtitration complement fixation (CF) test first detected anti­
bodies against M. hyopneumoniae in corresponding pigs. Correlation of LAT 
results in experimentally infected pigs, with gross and microscopic lung 
lesions, revealed that LAT antibodies persisted after the pneumonic le­
sions had resolved. 
Latex agglutination antibodies were detected up to 48 weeks post-
inoculation in two pigs intranasally inoculated with a M. hyopneumoniae 
broth culture. Complement fixation titers of the same two pigs lasted no 
longer than 28 weeks post-inoculation. 
Pigs in contact with M. hyopneumoniae inoculated pigs developed de­
tectable LAT antibodies 4 to 12 weeks post-contact. 
DEAE cellulose and 2-mercaptoethanol treatment of swine test sera 
indicated the antibodies detected by the latex agglutination test were 19S 
immunoglobulins. 
Correlation of latex agglutination titers and protection in swine 
against M. hyopneumoniae infection was shown. 
Repeatability of LAT results experiments revealed some variation of 
LAT titers of sera titered at four different times. 
Absorption of swine test sera with swine or sheep RBC was partially 
successful in removing nonspecific agglutinins. 
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Sera from pigs inoculated with M. hyosynoviae or hyorhinis did not 
react in the M. hvopneumoniae LAT. In addition, no detectable titers were 
demonstrated in the M. hvopneumoniae LAT using sera from pigs infected 
with Metastronqylus spp.. Ascaris suum, or in sera from pigs vaccinated 
with any of four commonly used swine vaccines. 
Preliminary chemical and physical treatments of M. hyopneumoniae 
indicated the LAT antigen was heat stable and soluble in ether and 
chloroform. 
Field evaluation of the LAT showed some correlation of LAT results 
with CF test results and gross and microscopic pneumonic lung lesions 
typical of MPS. 
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